<?xml version="1.0" encoding="UTF-8"?>
<hmdb xmlns="http://www.hmdb.ca"> 
<metabolite>
  <version>4.0</version>
  <creation_date>2005-11-16 15:48:42 UTC</creation_date>
  <update_date>2020-02-27 20:29:47 UTC</update_date>
  <accession>HMDB0000122</accession>
  <status>quantified</status>
  <secondary_accessions>
    <accession>HMDB0006564</accession>
    <accession>HMDB00122</accession>
    <accession>HMDB06564</accession>
  </secondary_accessions>
  <name>D-Glucose</name>
  <description>Glucose is a monosaccharide containing six carbon atoms and an aldehyde group and is therefore referred to as an aldohexose. The glucose molecule can exist in an open-chain (acyclic) and ring (cyclic) form, the latter being the result of an intramolecular reaction between the aldehyde C atom and the C-5 hydroxyl group to form an intramolecular hemiacetal. In water solution both forms are in equilibrium and at pH 7 the cyclic one is the predominant. Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. In animals glucose arises from the breakdown of glycogen in a process known as glycogenolysis. Glucose is synthesized in the liver and kidneys from non-carbohydrate intermediates, such as pyruvate and glycerol, by a process known as gluconeogenesis. D-Glucose is found to be associated with 3-methyl-crotonyl-glycinuria, growth hormone deficiency, and primary hypomagnesemia, which are inborn errors of metabolism.</description>
  <synonyms>
    <synonym>D-GLC</synonym>
    <synonym>D-GLCP</synonym>
    <synonym>Dextrose</synonym>
    <synonym>GLC-OH</synonym>
    <synonym>Glucose</synonym>
    <synonym>Grape sugar</synonym>
    <synonym>D-Glucopyranose</synonym>
    <synonym>Roferose ST</synonym>
    <synonym>(+)-Glucose</synonym>
    <synonym>Anhydrous dextrose</synonym>
    <synonym>Cerelose</synonym>
    <synonym>Cerelose 2001</synonym>
    <synonym>Clearsweet 95</synonym>
    <synonym>Clintose L</synonym>
    <synonym>Corn sugar</synonym>
    <synonym>CPC Hydrate</synonym>
    <synonym>D(+)-Glucose</synonym>
    <synonym>Dextropur</synonym>
    <synonym>Dextrosol</synonym>
    <synonym>Glucodin</synonym>
    <synonym>Glucolin</synonym>
    <synonym>Goldsugar</synonym>
    <synonym>Meritose</synonym>
    <synonym>Staleydex 111</synonym>
    <synonym>Staleydex 95m</synonym>
    <synonym>Tabfine 097(HS)</synonym>
    <synonym>Vadex</synonym>
    <synonym>D Glucose</synonym>
    <synonym>Glucose, (DL)-isomer</synonym>
    <synonym>Glucose, (L)-isomer</synonym>
    <synonym>Glucose, (beta-D)-isomer</synonym>
    <synonym>Glucose monohydrate</synonym>
    <synonym>Glucose, (alpha-D)-isomer</synonym>
    <synonym>L Glucose</synonym>
    <synonym>L-Glucose</synonym>
    <synonym>Dextrose, anhydrous</synonym>
    <synonym>Monohydrate, glucose</synonym>
  </synonyms>
  <chemical_formula>C6H12O6</chemical_formula>
  <average_molecular_weight>180.1559</average_molecular_weight>
  <monisotopic_molecular_weight>180.063388116</monisotopic_molecular_weight>
  <iupac_name>(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol</iupac_name>
  <traditional_iupac>glucose</traditional_iupac>
  <cas_registry_number>50-99-7</cas_registry_number>
  <smiles>[H]C1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O</smiles>
  <inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1</inchi>
  <inchikey>WQZGKKKJIJFFOK-GASJEMHNSA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity.</description>
    <direct_parent>Hexoses</direct_parent>
    <kingdom>Organic compounds</kingdom>
    <super_class>Organic oxygen compounds</super_class>
    <class>Organooxygen compounds</class>
    <sub_class>Carbohydrates and carbohydrate conjugates</sub_class>
    <molecular_framework>Aliphatic heteromonocyclic compounds</molecular_framework>
    <alternative_parents>
      <alternative_parent>Hemiacetals</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>Oxacyclic compounds</alternative_parent>
      <alternative_parent>Oxanes</alternative_parent>
      <alternative_parent>Polyols</alternative_parent>
      <alternative_parent>Primary alcohols</alternative_parent>
      <alternative_parent>Secondary alcohols</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>Alcohol</substituent>
      <substituent>Aliphatic heteromonocyclic compound</substituent>
      <substituent>Hemiacetal</substituent>
      <substituent>Hexose monosaccharide</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>Organoheterocyclic compound</substituent>
      <substituent>Oxacycle</substituent>
      <substituent>Oxane</substituent>
      <substituent>Polyol</substituent>
      <substituent>Primary alcohol</substituent>
      <substituent>Secondary alcohol</substituent>
    </substituents>
    <external_descriptors>
      <external_descriptor>Aldoses</external_descriptor>
      <external_descriptor>D-glucose</external_descriptor>
      <external_descriptor>glucopyranose</external_descriptor>
    </external_descriptors>
  </taxonomy>
  <ontology>
    <root>
      <term>Physiological effect</term>
      <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Health effect</term>
          <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
          <parent_id>7693</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Observation</term>
              <definition>A short term health effect which reflects the reponse of the body to stimuli or is a symptom of a disease or condition; also includes health status which reflects stage in life.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Neuropathy</term>
                  <definition>A nervous system disease that is located in nerves or nerve cells. (do).</definition>
                  <parent_id>7717</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Health condition</term>
              <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Diabetes mellitus type 2</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Non-insulin-dependent diabetes mellitus</synonym>
                    <synonym>Niddm</synonym>
                    <synonym>Adult-onset diabetes</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Growth hormone deficiency</term>
                  <definition>A finding based on laboratory test results that indicate abnormally low levels of growth hormone in a biological specimen.  (nci ctcae).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Ghd</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Schizophrenia</term>
                  <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Glucagon deficiency</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Hypoglykemia due to glucagon deficiency</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Addison's disease</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Hypocorticism</synonym>
                    <synonym>Hypocortisolism</synonym>
                    <synonym>Chronic adrenal insufficiency</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Ketoacidosis</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Gestational diabetes</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Gdm</synonym>
                    <synonym>Gestational diabetes mellitus</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Kidney disease</term>
                  <definition>A urinary system disease that is located in the kidney. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Renal disease</synonym>
                    <synonym>Nephropathy</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Hyperbilirubinemia</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Peripheral vascular disease</term>
                  <definition>A vascular disease that is characterized by obstruction of larger arteries not within the coronary, aortic arch vasculature, or brain. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Peripheral arterial disease</synonym>
                    <synonym>Paod</synonym>
                    <synonym>Peripheral artery occlusive disease</synonym>
                    <synonym>Pad</synonym>
                    <synonym>Peripheral artery disease</synonym>
                    <synonym>Pvd</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Diabetic ketoacidosis</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Coma</term>
                  <definition>A state of profound unconsciousness associated with markedly depressed cerebral activity. Causes include central nervous system damage, intoxication, and metabolic abnormalities.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Vascular disease</term>
                  <definition>A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Coronary artery disease</term>
                  <definition>An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Cad</synonym>
                    <synonym>Atherosclerotic heart disease</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Respiratory, thoracic and mediastinal disorders</term>
                  <definition>Any disorder (non-neoplastic or neoplastic)  that affects the respiratory system or the thorax including the mediastinum and the heart. (nci).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Respiratory distress</term>
                      <definition/>
                      <parent_id>7705</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Renal and urinary disorders</term>
                  <definition>Any disorder that affects the kidneys and the urologic system.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Chronic kidney disease</term>
                      <definition>A disorder characterized by gradual and usually permanent loss of kidney function resulting in renal failure. (nci ctcae).</definition>
                      <parent_id>7714</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Ckd</synonym>
                        <synonym>Chronic renal disease</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>General disorders and administration site conditions</term>
                  <definition>Any disorder that was not classified under a specific system.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pain</term>
                      <definition>A disorder characterized by the sensation of marked discomfort, distress or agony. (nci ctcae).</definition>
                      <parent_id>7711</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cardiac disorders</term>
                  <definition>Any disorder that affects the heart.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cardiovascular disease</term>
                      <definition/>
                      <parent_id>7698</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Heart disease</term>
                      <definition>A cardiovascular system disease that involves the heart. (do).</definition>
                      <parent_id>7698</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Nervous system disorders</term>
                  <definition>Any disorder (non-neoplastic or neoplastic) that affects the brain, spinal cord, or peripheral nerves.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Stroke</term>
                      <definition>A disorder characterized by a sudden loss of sensory function due to an intracranial vascular event. (nci ctcae).</definition>
                      <parent_id>7703</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cerebrovascular accident</synonym>
                        <synonym>Cva</synonym>
                        <synonym>Cerebrovascular insult</synonym>
                        <synonym>Cvi</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Gastrointestinal disorders</term>
                  <definition>Any disorder (non-neoplastic or neoplastic) that affects the gastrointestinal tract.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Vomiting</term>
                      <definition>A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth. (nci ctcae).</definition>
                      <parent_id>7700</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Nausea</term>
                      <definition>A disorder characterized by a queasy sensation and/or the urge to vomit. (nci ctcae).</definition>
                      <parent_id>7700</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Abdominal pain</term>
                      <definition>A disorder characterized by a sensation of marked discomfort in the abdominal region. (nci ctcae).</definition>
                      <parent_id>7700</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cancer</term>
                  <definition>A group of disorders characterized by the presense of malignant neoplasm.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Acute myelogenous leukemia</term>
                      <definition/>
                      <parent_id>7696</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Aml</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Metabolism and nutrition disorders</term>
                  <definition>A group of disorders, inherited or not, that result in a metabolic malfunction.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Hyperlipidemia</term>
                      <definition>A disorder characterized by laboratory test results that indicate an elevation in the concentration of lipids in blood. (nci ctcae).</definition>
                      <parent_id>7708</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Dyslipidemia</synonym>
                        <synonym>Hyperlipoproteinemia</synonym>
                        <synonym>Hyperlipidaemia</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>3-methyl-crotonyl-glycinuria</term>
                      <definition/>
                      <parent_id>7708</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>3-methylcrotonyl-coa carboxylase deficiency</synonym>
                        <synonym>3mcc deficiency</synonym>
                        <synonym>3-methylcrotonylglycinuria type 1</synonym>
                        <synonym>Bmcc deficiency</synonym>
                        <synonym>Beta-methylcrotonyl-coenzyme a carboxylase deficiency</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Disposition</term>
      <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Route of exposure</term>
          <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Enteral</term>
              <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
              <parent_id>7743</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Ingestion</term>
                  <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                  <parent_id>7744</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Digestion</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Source</term>
          <definition>Natural or synthetic origin of a chemical.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Endogenous</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Food</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Biological</term>
              <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Animal</term>
                  <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fauna</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Plant</term>
                  <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                    <synonym>Flora</synonym>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Poaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Gramineae</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Coffea</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Coffee bean</synonym>
                        <synonym>Coffee</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Fabaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Papilionoideae</synonym>
                        <synonym>Legume</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glycine max</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Soy</synonym>
                        <synonym>Soya</synonym>
                        <synonym>Soybean</synonym>
                        <synonym>Soya bean</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cucurbitaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cucurbits</synonym>
                        <synonym>Gourds</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Theobroma cacao</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological location</term>
          <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Organ and components</term>
              <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Gonad</term>
                  <definition>A reproductive system organ that produces and releases either sperm (testis) or eggs (ovary). (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Intestine</term>
                  <definition>The portion of the gastrointestinal tract that includes the small and large intestines.</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Bladder</term>
                  <definition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Mouth</term>
                  <definition>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Buccal cavity</synonym>
                    <synonym>Oral</synonym>
                    <synonym>Oral cavity</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Liver</term>
                  <definition>An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Prostate</term>
                  <definition>The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Prostate gland</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Pancreas</term>
                  <definition>A digestive organ in the abdomen that has both endocrine and exocrine functions. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Brain</term>
                  <definition>An organ composed of grey and white matter that is the center for intelligence and reasoning. it is protected by the bony cranium. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Lung</term>
                  <definition>A thoracic organ that has variable lobation and is the primary respiratory organ of mammals.</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Lungs</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Kidney</term>
                  <definition>The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Kidneys</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Endocrine gland</term>
                  <definition/>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Adrenal cortex</term>
                      <definition>The outer region of the adrenal gland consisting of the zona glomerulosa, the zona fasciculata, and the zona reticularis. The adrenal cortex produces and secretes mineralocorticoids, glucocorticoids, and adrenal androgens. (NCI).</definition>
                      <parent_id>7728</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Adrenal gland</term>
                      <definition>The endocrine glands adjacent to the kidneys that consist of the outer adrenal cortex and the inner adrenal medulla in mammals (nci).</definition>
                      <parent_id>7728</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Tissue and substructures</term>
              <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Adipose tissue</term>
                  <definition>A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fat tissue</synonym>
                    <synonym>Body fat</synonym>
                    <synonym>Adipose</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Placenta</term>
                  <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Epidermis</term>
                  <definition>The epithelial portion of the skin (cutis). it consists of the following layers: stratum corneum (horny layer), stratum granulosum (granular layer), stratum spinosum (prickle cell layer), and stratum basale (basal cell layer). (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Muscle</term>
                  <definition>A fibrous soft tissue with the ability to contract to produce force and motion. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biofluid and excreta</term>
              <definition>A liquid, semi-solid or solid material originating in the body.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Urine</term>
                  <definition>Excretion in liquid state processed by the kidney.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Saliva</term>
                  <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Feces</term>
                  <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fecal</synonym>
                    <synonym>Stool</synonym>
                    <synonym>Faecal</synonym>
                    <synonym>Faeces</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Blood</term>
                  <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Breast milk</term>
                  <definition>Portion of secreted substance produced by the mammary gland.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Sweat</term>
                  <definition>Secretion produced by a sweat gland.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cerebrospinal fluid</term>
                  <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Csf</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Cell and elements</term>
              <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Extracellular</term>
                  <definition>The space external to the outermost structure of a cell.</definition>
                  <parent_id>7732</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Extracellular region</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cell</term>
                  <definition/>
                  <parent_id>7732</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Nerve cell</term>
                      <definition>A cell in the nervous system, that is able to conduct weak electric signals between the brain and the body. A typical neuron consists of a cell body, containing the nucleus and the surrounding cytoplasm (perikaryon); several short radiating processes (dendrites); and one long process (the axon), which terminates in twiglike branches (telodendrons) and may have branches (collaterals) projecting along its course. (NCI).</definition>
                      <parent_id>7734</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Neuron</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Beta cell</term>
                      <definition>A cell that composes the bulk of the islets of Langerhans in the pancreas and secretes insulin.</definition>
                      <parent_id>7734</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Fibroblast</term>
                      <definition>A cell in the connective tissue, that makes and secretes collagen proteins.</definition>
                      <parent_id>7734</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Subcellular</term>
              <definition>An anatomical organizational level including a component within a biological cell .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Lysosome</term>
                  <definition>В A sac-like compartment inside a cell that has enzymes that can break down cellular components that need to be destroyed. (NCI).</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Endoplasmic reticulum</term>
                  <definition>A network of tubular membranes within the cytoplasm of the cell, occurring either with a smooth surface (smooth endoplasmic reticulum) or studded with ribosomes (rough endoplasmic reticulum), involved in the transport of materials. (Infoplease Dictionary via NCI)</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Er</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Golgi</term>
                  <definition>A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. Note that the Golgi apparatus can be located in various places in the cytoplasm. </definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Golgi apparatus</synonym>
                    <synonym>Golgi complex</synonym>
                    <synonym>Golgi ribbon</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Myelin sheath</term>
                  <definition>A layer of phospholipids and protein found on neuronal axons. this structure acts as an electrical insulator that allows nerve impulses to travel faster by increasing the resistance and decreasing the capacitance over that found in unmyelinated nerve fibers. (nci).</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Myelin</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Process</term>
      <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Naturally occurring process</term>
          <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
          <parent_id>7659</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biological process</term>
              <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
              <parent_id>7660</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biochemical pathway</term>
                  <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                  <parent_id>7661</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Congenital disorder of glycosylation CDG-IId</term>
                      <definition> these glycoconjugates play critical roles in metabolism, cell recognition and adhesion, cell migration, protease resistance, host defense, and antigenicity, among others. cdgs are divided into 2 main groups: type i cdgs (see, e.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Galactose metabolism</term>
                      <definition> the main sources of galactose in the human diet are milk and milk products. the milk sugar, lactose, is hydrolyzed in the intestine to its constituent monosaccharides, glucose and galactose.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glibenclamide Action Pathway</term>
                      <definition> glibenclamide acts on pancreatic beta-cells to stimulate insulin secretion. under physiological conditions, insulin secretion from beta-cells is mediated by elevated glucose concentration in the blood.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Gliclazide Action Pathway</term>
                      <definition> gliclazide acts on pancreatic beta-cells to stimulate insulin secretion. under physiological conditions, insulin secretion from beta-cells is mediated by elevated glucose concentration in the blood.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Globoid Cell Leukodystrophy</term>
                      <definition> a defect in this enzyme results in accumulation of galactosylceramide and psychosine in central nervous system. infants with krabbe disease are normal at birth.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>gluconeogenesis</term>
                      <definition> in animals, gluconeogenesis takes place mainly in the liver and, to a lesser extent, in the cortex of kidneys. this process occurs during periods of fasting, starvation, or intense exercise.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glucose-Alanine Cycle</term>
                      <definition> alanine plays a key role in glucose-alanine cycle between tissues and liver. in muscle and other tissues that degrade amino acids for fuel, amino groups are collected in the form of glutamate by transamination.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glycogenosis, Type IB</term>
                      <definition> the accumulation of glycogen in certain organs and tissues, especially the liver, kidneys, and small intestines, impairs their ability to function normally. people with gsdi may experience delayed puberty.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glycogenosis, Type IC</term>
                      <definition> the accumulation of glycogen in certain organs and tissues, especially the liver, kidneys, and small intestines, impairs their ability to function normally. people with gsdi may experience delayed puberty.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>glycolysis</term>
                      <definition> the free energy released in this process is used to form the high energy compounds, atp (adenosine triphosphate) and nadh (reduced nicotinamide adenine dinucleotide). glycolysis is a sequence of ten reactions involving ten intermediate compounds.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Insulin Signalling</term>
                      <definition> it stimulates the storage of energy and inhibits the breakdown of high energy metabolites. glycogen and lipid biosynthesis is unregulated and conversely glycogen and fatty acid metabolism is down regulated.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Lactose Degradation</term>
                      <definition> alpha-lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother’s milk. lactose is also an important osmotic regulator of lactation.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Lactose intolerance</term>
                      <definition> its activity declines following weaning. as a result, adult mammals are normally lactose-intolerant and more than 75% of the human adult population suffers from lactase deficiency.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Lactose Synthesis</term>
                      <definition> lactose is created by joining two monosaccarides with a b1,4 glycosidic bond. glucose is first converted to udp-galactose via the enzyme galactose-1-phosphate uridylyltransferase.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Metachromatic Leukodystrophy (MLD)</term>
                      <definition> a defect in this enzyme results in accumulation of 3-o-sulfogalactosylceramide in urine, neural and non neural tisues like kidney and gallbladder. there are several forms of mld.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Nateglinide Action Pathway</term>
                      <definition> as the name of the drug class suggests, nateglinide acts on pancreatic beta-cells to stimulate insulin secretion. under physiological conditions, insulin secretion from beta-cells is mediated by elevated glucose concentration in the blood.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Pancreas Function</term>
                      <definition> it is both an endocrine gland producing several important hormones, including insulin, glucagon, somatostatin, and pancreatic polypeptide, and a digestive organ, secreting pancreatic juice containing digestive enzymes that assist the absorption of nutrients and the digestion in the small intestine. these enzymes help to further break down the carbohydrates, proteins, and lipids in the chyme.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Repaglinide Action Pathway</term>
                      <definition> as the name of the drug class suggests, repaglinide acts on pancreatic beta-cells to stimulate insulin secretion. under physiological conditions, insulin secretion from beta-cells is mediated by elevated glucose concentration in the blood.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Sphingolipid Metabolism</term>
                      <definition> the core of sphingolipids is the long-chain amino alcohol, sphingosine. amino acylation, with a long chain fatty acid, at carbon 2 of sphingosine yields a ceramide.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Transfer of Acetyl Groups into Mitochondria</term>
                      <definition> acetyl coa participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. it also acts as a biological acetylating agent.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Triosephosphate isomerase</term>
                      <definition> it is the most severe glycolytic enzyme defect associated with progressive neurologic dysfunction.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Warburg effect</term>
                      <definition> as the krebs cycle is an aerobic process, in normal cells lactate production is reserved for anaerobic conditions. however, cancer cells preferentially utilize glucose for lactate production via this “aerobic glycolysis”, even when oxygen is plentiful.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Aerobic glycolysis</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Role</term>
      <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Industrial application</term>
          <definition>The assumed function of a chemical utilized by human.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Food and nutrition</term>
              <definition>A chemical purpose related to manufacturing of food and nutrition products.</definition>
              <parent_id>7678</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological role</term>
          <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Metabolite</term>
              <definition>A chemical substance produced during metabolism process, as an intermediate or end-product.</definition>
              <parent_id>7672</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
  </ontology>
  <state>Solid</state>
  <experimental_properties>
    <property>
      <kind>water_solubility</kind>
      <value>1200.0 mg/mL</value>
      <source/>
    </property>
    <property>
      <kind>logp</kind>
      <value>-3.24</value>
      <source>SANGSTER (1994)</source>
    </property>
    <property>
      <kind>melting_point</kind>
      <value>146 - 150 °C</value>
      <source/>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>-2.57</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>0.64</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>782 g/L</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>-2.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>11.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>-3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>180.1559</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>180.063388116</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>[H]C1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C6H12O6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>WQZGKKKJIJFFOK-GASJEMHNSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>110.38</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>35.92</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>16.37</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <spectra>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1093</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1152</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>1151</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>334</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>335</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>336</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>337</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1428</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1598</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1601</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1632</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1707</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>2406</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30344</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30345</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30766</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30767</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31005</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31006</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31007</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31008</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31009</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>37304</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>177</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>178</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>179</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2913</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2914</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2915</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2916</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2917</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>178080</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>178081</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>178082</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>180393</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>180394</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>180395</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437657</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437658</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437659</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437660</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437661</spectrum_id>
    </spectrum>
  </spectra>
  <biological_properties>
    <cellular_locations>
      <cellular>Endoplasmic reticulum</cellular>
      <cellular>Extracellular</cellular>
      <cellular>Golgi apparatus</cellular>
      <cellular>Lysosome</cellular>
    </cellular_locations>
    <biospecimen_locations>
      <biospecimen>Blood</biospecimen>
      <biospecimen>Breast Milk</biospecimen>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <biospecimen>Feces</biospecimen>
      <biospecimen>Saliva</biospecimen>
      <biospecimen>Sweat</biospecimen>
      <biospecimen>Urine</biospecimen>
    </biospecimen_locations>
    <tissue_locations>
      <tissue>Adipose Tissue</tissue>
      <tissue>Adrenal Cortex</tissue>
      <tissue>Adrenal Gland</tissue>
      <tissue>Adrenal Medulla</tissue>
      <tissue>Beta Cell</tissue>
      <tissue>Bladder</tissue>
      <tissue>Brain</tissue>
      <tissue>Brain Plaques</tissue>
      <tissue>Epidermis</tissue>
      <tissue>Eye Lens</tissue>
      <tissue>Fetus</tissue>
      <tissue>Fibroblasts</tissue>
      <tissue>Gonads</tissue>
      <tissue>Gut</tissue>
      <tissue>Intestine</tissue>
      <tissue>Kidney</tissue>
      <tissue>Liver</tissue>
      <tissue>Lung</tissue>
      <tissue>Mouth</tissue>
      <tissue>Muscle</tissue>
      <tissue>Myelin</tissue>
      <tissue>Nerve Cells</tissue>
      <tissue>Neuron</tissue>
      <tissue>Pancreas</tissue>
      <tissue>Placenta</tissue>
      <tissue>Prostate</tissue>
    </tissue_locations>
    <pathways>
      <pathway>
        <name>Congenital disorder of glycosylation CDG-IId</name>
        <smpdb_id>SMP00579</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Fabry disease</name>
        <smpdb_id>SMP00525</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Fanconi-bickel syndrome</name>
        <smpdb_id>SMP00572</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Fructose-1,6-diphosphatase deficiency</name>
        <smpdb_id>SMP00562</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Galactose Metabolism</name>
        <smpdb_id>SMP00043</smpdb_id>
        <kegg_map_id>map00052</kegg_map_id>
      </pathway>
      <pathway>
        <name>Galactosemia</name>
        <smpdb_id>SMP00182</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Gaucher Disease</name>
        <smpdb_id>SMP00349</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glibenclamide Action Pathway</name>
        <smpdb_id>SMP00460</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Gliclazide Action Pathway</name>
        <smpdb_id>SMP00461</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Globoid Cell Leukodystrophy</name>
        <smpdb_id>SMP00348</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Gluconeogenesis</name>
        <smpdb_id>SMP00128</smpdb_id>
        <kegg_map_id>map00010</kegg_map_id>
      </pathway>
      <pathway>
        <name>Glucose-Alanine Cycle</name>
        <smpdb_id>SMP00127</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>GLUT-1 deficiency syndrome</name>
        <smpdb_id>SMP00580</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease</name>
        <smpdb_id>SMP00374</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycogenosis, Type IA. Von gierke disease</name>
        <smpdb_id>SMP00581</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycogenosis, Type IB</name>
        <smpdb_id>SMP00573</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycogenosis, Type IC</name>
        <smpdb_id>SMP00574</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycogenosis, Type VII. Tarui disease</name>
        <smpdb_id>SMP00531</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycolysis</name>
        <smpdb_id>SMP00040</smpdb_id>
        <kegg_map_id>map00010</kegg_map_id>
      </pathway>
      <pathway>
        <name>Insulin Signalling</name>
        <smpdb_id>SMP00391</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Krabbe disease</name>
        <smpdb_id>SMP00526</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Lactose Degradation</name>
        <smpdb_id>SMP00457</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>Lactose Intolerance</name>
        <smpdb_id>SMP00458</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Lactose Synthesis</name>
        <smpdb_id>SMP00444</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>Metachromatic Leukodystrophy (MLD)</name>
        <smpdb_id>SMP00347</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Nateglinide Action Pathway</name>
        <smpdb_id>SMP00453</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Pancreas Function</name>
        <smpdb_id>SMP00643</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)</name>
        <smpdb_id>SMP00560</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Repaglinide Action Pathway</name>
        <smpdb_id>SMP00454</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Sphingolipid Metabolism</name>
        <smpdb_id>SMP00034</smpdb_id>
        <kegg_map_id>map00500</kegg_map_id>
      </pathway>
      <pathway>
        <name>Transfer of Acetyl Groups into Mitochondria</name>
        <smpdb_id>SMP00466</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>Triosephosphate isomerase</name>
        <smpdb_id>SMP00563</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Warburg Effect</name>
        <smpdb_id>SMP00654</smpdb_id>
        <kegg_map_id/>
      </pathway>
    </pathways>
  </biological_properties>
  <normal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3100-5600</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gibson KM, Burlingame TG, Hogema B, Jakobs C, Schutgens RB, Millington D, Roe CR, Roe DS, Sweetman L, Steiner RD, Linck L, Pohowalla P, Sacks M, Kiss D, Rinaldo P, Vockley J: 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of L-isoleucine metabolism. Pediatr Res. 2000 Jun;47(6):830-3.</reference_text>
          <pubmed_id>10832746</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3890-5550</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Conboy E, Vairo F, Schultz M, Agre K, Ridsdale R, Deyle D, Oglesbee D, Gavrilov D, Klee EW, Lanpher B: Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features. JIMD Rep. 2017 Oct 14. doi: 10.1007/8904_2017_59.</reference_text>
          <pubmed_id>29030856</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4860 (4670-5190)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Age is 15-37 years old</comment>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3300-6900</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Staufner C, Haack TB, Kopke MG, Straub BK, Kolker S, Thiel C, Freisinger P, Baric I, McKiernan PJ, Dikow N, Harting I, Beisse F, Burgard P, Kotzaeridou U, Lenz D, Kuhr J, Himbert U, Taylor RW, Distelmaier F, Vockley J, Ghaloul-Gonzalez L, Ozolek JA, Zschocke J, Kuster A, Dick A, Das AM, Wieland T, Terrile C, Strom TM, Meitinger T, Prokisch H, Hoffmann GF: Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis. 2016 Jan;39(1):3-16. doi: 10.1007/s10545-015-9896-7. Epub 2015 Nov 5.</reference_text>
          <pubmed_id>26541327</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5000 +/- 600</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, Blanche H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P: Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes. 1996 Apr;45(4):478-87.</reference_text>
          <pubmed_id>8603770</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4200-6300</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Vieira P, Cameron J, Rahikkala E, Keski-Filppula R, Zhang LH, Santra S, Matthews A, Myllynen P, Nuutinen M, Moilanen JS, Rodenburg RJ, Rolfs A, Uusimaa J, van Karnebeek CDM: Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction. Mol Genet Metab. 2017 Apr;120(4):337-341. doi: 10.1016/j.ymgme.2017.02.003. Epub  2017 Feb 6.</reference_text>
          <pubmed_id>28216384</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3500-6000</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Santra S, Cameron JM, Shyr C, Zhang L, Drogemoller B, Ross CJ, Wasserman WW, Wevers RA, Rodenburg RJ, Gupte G, Preece MA, van Karnebeek CD: Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis. Mol Genet Metab. 2016 May;118(1):21-7. doi: 10.1016/j.ymgme.2016.03.001. Epub 2016 Mar 4.</reference_text>
          <pubmed_id>26971250</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5350.0 +/- 120.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Darzy KH, Murray RD, Gleeson HK, Pezzoli SS, Thorner MO, Shalet SM: The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J Clin Endocrinol Metab. 2006 Mar;91(3):987-94. Epub 2005 Dec 29.</reference_text>
          <pubmed_id>16384844</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5400.0 (4700.0 - 6100.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tatidis L, Vitols S, Gruber A, Paul C, Axelson M: Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. Cancer Lett. 2001 Sep 20;170(2):169-75.</reference_text>
          <pubmed_id>11463495</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3300-5600</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
          <pubmed_id>23430856</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3885.524-6105.823</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Lalani SR, Liu P, Rosenfeld JA, Watkin LB, Chiang T, Leduc MS, Zhu W, Ding Y, Pan S, Vetrini F, Miyake CY, Shinawi M, Gambin T, Eldomery MK, Akdemir ZH, Emrick L, Wilnai Y, Schelley S, Koenig MK, Memon N, Farach LS, Coe BP, Azamian M, Hernandez P, Zapata G, Jhangiani SN, Muzny DM, Lotze T, Clark G, Wilfong A, Northrup H, Adesina A, Bacino CA, Scaglia F, Bonnen PE, Crosson J, Duis J, Maegawa GH, Coman D, Inwood A, McGill J, Boerwinkle E, Graham B, Beaudet A, Eng CM, Hanchard NA, Xia F, Orange JS, Gibbs RA, Lupski JR, Yang Y: Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations. Am J Hum Genet. 2016 Feb 4;98(2):347-57. doi: 10.1016/j.ajhg.2015.12.008. Epub 2016 Jan 21.</reference_text>
          <pubmed_id>26805781</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4163.0610-6383.360</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999 Sep 16;341(12):879-84. doi: 10.1056/NEJM199909163411204.</reference_text>
          <pubmed_id>10486419</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;5994.808</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A, Gibson S, Taylor K, Carr C: Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1995 Nov 23;333(21):1386-90. doi: 10.1056/NEJM199511233332104.</reference_text>
          <pubmed_id>7477119</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2800-5000</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
          <pubmed_id>12072887</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3885.524-6105.823</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Santarelli F, Cassanello M, Enea A, Poma F, D'Onofrio V, Guala G, Garrone G, Puccinelli P, Caruso U, Porta F, Spada M: A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr. 2013 May 24;39:33. doi: 10.1186/1824-7288-39-33.</reference_text>
          <pubmed_id>23705938</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5181.0 +/- 394.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Sinha S, Misra A, Kumar V, Jagannathan NR, Bal CS, Pandey RM, Singhania R, Deepak: Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities. Clin Endocrinol (Oxf). 2004 Aug;61(2):182-9.</reference_text>
          <pubmed_id>15272912</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4380 +/-275</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4500 +/- 1000</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>At end of 120 minute hyperglycemic clamp.</comment>
      <references>
        <reference>
          <reference_text>Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, Blanche H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P: Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes. 1996 Apr;45(4):478-87.</reference_text>
          <pubmed_id>8603770</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4894.19(1723.06)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
          <pubmed_id>26010610</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by GC-MS</comment>
      <references>
        <reference>
          <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
          <pubmed_id>22007635</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4000.0-6000.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>The reference range has been derived from internal data at Molecular You, in addition to these published references: PMID 11463495; MedlinePlus (https://medlineplus.gov/ency/article/003482.htm)</comment>
      <references>
        <reference>
          <reference_text>Molecular You: https://molecularyou.com</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by 1H NMR</comment>
      <references>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4823.600 +/- 249.784</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Evening.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5300.0 (4900.0 - 5700.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC: Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol. 1999 Apr;33(4):652-8.</reference_text>
          <pubmed_id>10218738</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4695.933 +/- 327.494</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Morning.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4750.0 +/- 184.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2200.0 (1100.0 - 3300.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wu AHB (2006) Tietz clinical guide to laboratory tests, 4th ed. WB Saunders, St. Louis.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4440.0 +/- 370.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4570.0 +/- 411.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2750.0 (2200.0-3300.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wu AHB (2006) Tietz clinical guide to laboratory tests, 4th ed. WB Saunders, St. Louis.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4470.0 +/- 346.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4450.0 (3300.0 - 5600.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wu AHB (2006) Tietz clinical guide to laboratory tests, 4th ed. WB Saunders, St. Louis.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5450.0 (4200.0 - 6700.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Elderly (&gt;65 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wu AHB (2006) Tietz clinical guide to laboratory tests, 4th ed. WB Saunders, St. Louis.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3500-7000</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA: Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr. 2003 Jun;142(6):684-9. doi: 10.1067/mpd.2003.231.</reference_text>
          <pubmed_id>12838198</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4971.3 +/- 372.8</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4440.0 +/- 100.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ: Increased postprandial triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 Mar;38(3):527-33.</reference_text>
          <pubmed_id>16540841</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4470.0 +/- 110.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Exercise</comment>
      <references>
        <reference>
          <reference_text>Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ: Increased postprandial triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 Mar;38(3):527-33.</reference_text>
          <pubmed_id>16540841</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Breast Milk</biospecimen>
      <concentration_value>1500 +/- 530</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Samples collected in the morning on day 90 postpartum. Metabolite was measured by using 1H NMR spectroscopy.</comment>
      <references>
        <reference>
          <reference_text>Smilowitz JT, O'Sullivan A, Barile D, German JB, Lonnerdal B, Slupsky CM: The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr. 2013 Nov;143(11):1709-18. doi: 10.3945/jn.113.178772. Epub 2013 Sep 11.</reference_text>
          <pubmed_id>24027187</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Breast Milk</biospecimen>
      <concentration_value>4500.0+/- 100.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Cavalli C, Teng C, Battaglia FC, Bevilacqua G: Free sugar and sugar alcohol concentrations in human breast milk. J Pediatr Gastroenterol Nutr. 2006 Feb;42(2):215-21.</reference_text>
          <pubmed_id>16456418</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>2500-4000</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Leen WG, Willemsen MA, Wevers RA, Verbeek MM: Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice. PLoS One. 2012;7(8):e42745. doi: 10.1371/journal.pone.0042745. Epub 2012 Aug 6.</reference_text>
          <pubmed_id>22880096</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>2960 +/- 1110</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
          <pubmed_id>18502700</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>2775.374-3885.524</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hommes FA, Polman HA, Reerink JD: Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child. 1968 Aug;43(230):423-6.</reference_text>
          <pubmed_id>4873809</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>5390.0 +/- 1650.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Commodari F, Arnold DL, Sanctuary BC, Shoubridge EA: 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient. NMR Biomed. 1991 Aug;4(4):192-200.</reference_text>
          <pubmed_id>1931558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>1720.0 (1560.0-1880.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
          <pubmed_id>15627241</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-MS on lyophilized fecal samples from premature breast milk-fed infants</comment>
      <references>
        <reference>
          <reference_text>Poroyko V, Morowitz M, Bell T, Ulanov A, Wang M, Donovan S, Bao N, Gu S, Hong L, Alverdy JC, Bergelson J, Liu DC: Diet creates metabolic niches in the "immature gut" that shape microbial communities. Nutr Hosp. 2011 Nov-Dec;26(6):1283-95. doi: 10.1590/S0212-16112011000600015.</reference_text>
          <pubmed_id>22411374</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=9) were used in the study.  Instrument: 1H NMR . Technology specification: 600MHz 1D; 2D; TOCSY, HSQC NMR.</comment>
      <references>
        <reference>
          <reference_text>Lamichhane S, Yde CC, Schmedes MS, Jensen HM, Meier S, Bertram HC: Strategy for Nuclear-Magnetic-Resonance-Based Metabolomics of Human Feces. Anal Chem. 2015 Jun 16;87(12):5930-7. doi: 10.1021/acs.analchem.5b00977. Epub 2015 May 28.</reference_text>
          <pubmed_id>25985090</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>743</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=51) were used in the study.  Instrument: 1H NMR. Technology specification: 600MHz 1D NMR. The original concentration was reported as 0.743 umol/g of wet feces.</comment>
      <references>
        <reference>
          <reference_text>De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, Serrazanetti DI, Di Cagno R, Ferrocino I, Lazzi C, Turroni S, Cocolin L, Brigidi P, Neviani E, Gobbetti M, O'Toole PW, Ercolini D: High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016 Nov;65(11):1812-1821. doi: 10.1136/gutjnl-2015-309957. Epub 2015 Sep 28.</reference_text>
          <pubmed_id>26416813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>18271</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=51) were used in the study.  Instrument: 1H NMR. Technology specification: 600MHz 1D NMR. The original concentration was reported as 18.271 umol/g of wet feces.</comment>
      <references>
        <reference>
          <reference_text>De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, Serrazanetti DI, Di Cagno R, Ferrocino I, Lazzi C, Turroni S, Cocolin L, Brigidi P, Neviani E, Gobbetti M, O'Toole PW, Ercolini D: High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016 Nov;65(11):1812-1821. doi: 10.1136/gutjnl-2015-309957. Epub 2015 Sep 28.</reference_text>
          <pubmed_id>26416813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>9717</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=51) were used in the study.  Instrument: 1H NMR. Technology specification: 600MHz 1D NMR. The original concentration was reported as 9.717 umol/g of wet feces.</comment>
      <references>
        <reference>
          <reference_text>De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, Serrazanetti DI, Di Cagno R, Ferrocino I, Lazzi C, Turroni S, Cocolin L, Brigidi P, Neviani E, Gobbetti M, O'Toole PW, Ercolini D: High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016 Nov;65(11):1812-1821. doi: 10.1136/gutjnl-2015-309957. Epub 2015 Sep 28.</reference_text>
          <pubmed_id>26416813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Capuani G, Tomassini A, Campagna G, Picchio M, Giorgetti G, Fabiocchi F, Brandimarte G: Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon. J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S9-S12. doi: 10.1097/MCG.0000000000000626.</reference_text>
          <pubmed_id>27622378</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
          <pubmed_id>27107423</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=183) were used in the study.  </comment>
      <references>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
          <pubmed_id>27543620</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>GC-MS on fecal extract</comment>
      <references>
        <reference>
          <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
          <pubmed_id>20669995</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
      <references>
        <reference>
          <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
          <pubmed_id>29808030</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal extact</comment>
      <references>
        <reference>
          <reference_text>Jacobs DM, Deltimple N, van Velzen E, van Dorsten FA, Bingham M, Vaughan EE, van Duynhoven J: (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 2008 Jul;21(6):615-26.</reference_text>
          <pubmed_id>18085514</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Yen S, McDonald JA, Schroeter K, Oliphant K, Sokolenko S, Blondeel EJ, Allen-Vercoe E, Aucoin MG: Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. J Proteome Res. 2015 Mar 6;14(3):1472-82. doi: 10.1021/pr5011247. Epub 2015 Feb 25.</reference_text>
          <pubmed_id>25670064</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>20 (&lt;1-914)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated non-smoker (n=23)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>197 (&lt;1-10764)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated smoker (n=23)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>247 (&lt;1-6510)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated smoker and non-smoker (n=20)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>90 (&lt;1-1994)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated smoker and non-smoker (n=20)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>817.300 +/- 1070.700 </concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>1-2762</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>normal</subject_condition>
      <comment>At rest without stimulation</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>4-389</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>normal</subject_condition>
      <comment>Salivary induction with a citric acid solution applied directly to the  tongue (stimulated)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>355.05  +/-  260.74</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>&gt;10</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Harada H, Shimizu H, Maeiwa M: 1H-NMR of human saliva. An application of NMR spectroscopy in forensic science. Forensic Sci Int. 1987 Jul;34(3):189-95.</reference_text>
          <pubmed_id>3666622</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value>230-300</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (60 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Sweat (Forehead)</comment>
      <references>
        <reference>
          <reference_text>Kutyshenko VP, Molchanov M, Beskaravayny P, Uversky VN, Timchenko MA: Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS One. 2011;6(12):e28824. doi: 10.1371/journal.pone.0028824. Epub 2011 Dec 14.</reference_text>
          <pubmed_id>22194922</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value>&lt; 10</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (40 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Sweat (Arms)</comment>
      <references>
        <reference>
          <reference_text>Kutyshenko VP, Molchanov M, Beskaravayny P, Uversky VN, Timchenko MA: Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS One. 2011;6(12):e28824. doi: 10.1371/journal.pone.0028824. Epub 2011 Dec 14.</reference_text>
          <pubmed_id>22194922</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult </subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Delgado-Povedano MM, Calderon-Santiago M, Priego-Capote F, Luque de Castro MD: Development of a method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry in high resolution mode. Anal Chim Acta. 2016 Jan 28;905:115-25. doi: 10.1016/j.aca.2015.11.048. Epub 2015 Dec 17.</reference_text>
          <pubmed_id>26755145</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>35.6 (10.3-56.7)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>by GC-MS</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J: SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012 Nov;404(8):2349-61. doi: 10.1007/s00216-012-6339-2. Epub  2012 Aug 31.</reference_text>
          <pubmed_id>22932811</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.0 (0.0-50.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>9.0 (0.0-19.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9.</reference_text>
          <pubmed_id>21389975</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>16.66-111.07</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>David F. Putnam Composition and Concentrative Properties of Human Urine. NASA Contractor Report. July 1971</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>37.5 (12.5-58.4)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>urine by NMR</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>31.12</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Shaykhutdinov RA, MacInnis GD, Dowlatabadi R, Weljie AM, Vogel HJ.  Quantitative analysis of metabolite concentrations in human urine samples using 13C{1H} NMR spectroscopy.  Metabolomics.  2009</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by 1H NMR</comment>
      <references>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7.0 (0.0-15.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>25.8 +/- 13.82</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>143.14 +/- 399.78</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
          <pubmed_id>2026685</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>31.598 +/- 15.976</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>107.8-1946</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. Healthy and term-neonate’s urinary metabolites concentration values measured by targeted metabolomics (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>481.1(156.9-1213)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. Healthy and term-neonate’s urinary metabolites concentration values measured by targeted metabolomics (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>392.8(94.56-2159)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. Healthy and term-neonate’s urinary metabolites concentration values measured by targeted metabolomics (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>76-800</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By H-NMR 600 MHz BRUKER spectrometers</comment>
      <references>
        <reference>
          <reference_text>Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Anso S, Echevarria LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MA, Legorburu AP, Fang F, Astigarraga I, Schafer H, Spraul M, Millet O: NMR-based newborn urine screening for optimized detection of inherited errors of metabolism. Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.</reference_text>
          <pubmed_id>31506554</pubmed_id>
        </reference>
      </references>
    </concentration>
  </normal_concentrations>
  <abnormal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&gt;11100</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes mellitus</patient_information>
      <comment>Casual blood glucose test</comment>
      <references>
        <reference>
          <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1000-4100</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021.</reference_text>
          <pubmed_id>9727719</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&gt;7000</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes mellitus</patient_information>
      <comment>Fasting glucose test</comment>
      <references>
        <reference>
          <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2800</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>2-Methylbutyryl-CoA dehydrogenase deficiency (SBACDD)</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Gibson KM, Burlingame TG, Hogema B, Jakobs C, Schutgens RB, Millington D, Roe CR, Roe DS, Sweetman L, Steiner RD, Linck L, Pohowalla P, Sacks M, Kiss D, Rinaldo P, Vockley J: 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of L-isoleucine metabolism. Pediatr Res. 2000 Jun;47(6):830-3.</reference_text>
          <pubmed_id>10832746</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5828.285-15264.557</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>21-hydroxylase deficiency</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Warinner SA, Zimmerman D, Thompson GB, Grant CS: Study of three patients with congenital adrenal hyperplasia treated by bilateral adrenalectomy. World J Surg. 2000 Nov;24(11):1347-52.</reference_text>
          <pubmed_id>11038205</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2997.404</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adolescent (13-18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=1. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3743 +/- 1272.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Heart Transplant</patient_information>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3108.419</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=1. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2053.777-2220.299</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=3. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3890</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Conboy E, Vairo F, Schultz M, Agre K, Ridsdale R, Deyle D, Oglesbee D, Gavrilov D, Klee EW, Lanpher B: Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features. JIMD Rep. 2017 Oct 14. doi: 10.1007/8904_2017_59.</reference_text>
          <pubmed_id>29030856</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2164.792-2553.344</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=3. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1300-1400</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;2600</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency</patient_information>
      <comment>Patient has hyperinsulinism. n=1</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2164.792</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Fanconi Bickel syndrome</patient_information>
      <comment>Fasting glucose</comment>
      <references>
        <reference>
          <reference_text>Late Diagnosis of Fanconi-Bickel Syndrome: Challenges With the Diagnosis and Literature Review </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>42460</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Wolcott-Rallison syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Neonatal diabetes in Wolcott-Rallison syndrome: a case report</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>6150 (5000-10090)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Lipodystrophy</patient_information>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>7830 (5220-10890)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Lipodystrophy, Congenital Generalized</patient_information>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>390</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Long-chain Fatty Acids, Defect in Transport of</patient_information>
      <references>
        <reference>
          <reference_text>Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006.</reference_text>
          <pubmed_id>3185635</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>400</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Infantile Liver Failure Syndrome 2</patient_information>
      <references>
        <reference>
          <reference_text>Staufner C, Haack TB, Kopke MG, Straub BK, Kolker S, Thiel C, Freisinger P, Baric I, McKiernan PJ, Dikow N, Harting I, Beisse F, Burgard P, Kotzaeridou U, Lenz D, Kuhr J, Himbert U, Taylor RW, Distelmaier F, Vockley J, Ghaloul-Gonzalez L, Ozolek JA, Zschocke J, Kuster A, Dick A, Das AM, Wieland T, Terrile C, Strom TM, Meitinger T, Prokisch H, Hoffmann GF: Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis. 2016 Jan;39(1):3-16. doi: 10.1007/s10545-015-9896-7. Epub 2015 Nov 5.</reference_text>
          <pubmed_id>26541327</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5060 (4670-6560)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Partial lipodystrophy</patient_information>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>900</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Phosphoenolpyruvate Carboxykinase Deficiency 1, Cytosolic</patient_information>
      <references>
        <reference>
          <reference_text>Vieira P, Cameron J, Rahikkala E, Keski-Filppula R, Zhang LH, Santra S, Matthews A, Myllynen P, Nuutinen M, Moilanen JS, Rodenburg RJ, Rolfs A, Uusimaa J, van Karnebeek CDM: Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction. Mol Genet Metab. 2017 Apr;120(4):337-341. doi: 10.1016/j.ymgme.2017.02.003. Epub  2017 Feb 6.</reference_text>
          <pubmed_id>28216384</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>800-3200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Phosphoenolpyruvate Carboxykinase Deficiency 1, Cytosolic</patient_information>
      <references>
        <reference>
          <reference_text>Vieira P, Cameron J, Rahikkala E, Keski-Filppula R, Zhang LH, Santra S, Matthews A, Myllynen P, Nuutinen M, Moilanen JS, Rodenburg RJ, Rolfs A, Uusimaa J, van Karnebeek CDM: Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction. Mol Genet Metab. 2017 Apr;120(4):337-341. doi: 10.1016/j.ymgme.2017.02.003. Epub  2017 Feb 6.</reference_text>
          <pubmed_id>28216384</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2800</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Phosphoenolpyruvate Carboxykinase Deficiency 1, Cytosolic</patient_information>
      <references>
        <reference>
          <reference_text>Santra S, Cameron JM, Shyr C, Zhang L, Drogemoller B, Ross CJ, Wasserman WW, Wevers RA, Rodenburg RJ, Gupte G, Preece MA, van Karnebeek CD: Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis. Mol Genet Metab. 2016 May;118(1):21-7. doi: 10.1016/j.ymgme.2016.03.001. Epub 2016 Mar 4.</reference_text>
          <pubmed_id>26971250</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4133.0 +/- 903.7 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
      <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3848.99 +/- 783.5 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1110.15</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Fructose-1,6-bisphosphatase deficiency</patient_information>
      <comment>During episode of lactic acidosis</comment>
      <references>
        <reference>
          <reference_text>Pagliara AS, Karl IE, Keating JP, Brown BI, Kipnis DM: Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J Clin Invest. 1972 Aug;51(8):2115-23. doi: 10.1172/JCI107018.</reference_text>
          <pubmed_id>4341015</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1665.224-2775.374</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Hypoglycemia, familial neonatal</patient_information>
      <comment>Fasting glucose. Lower than control.</comment>
      <references>
        <reference>
          <reference_text>COCHRANE WA, PAYNE WW, SIMPKISS MJ, WOOLF LI: Familial hypoglycemia precipitated by amino acids. J Clin Invest. 1956 Apr;35(4):411-22. doi: 10.1172/JCI103292.</reference_text>
          <pubmed_id>13306783</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2553.344</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Leigh Syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Hommes FA, Polman HA, Reerink JD: Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child. 1968 Aug;43(230):423-6.</reference_text>
          <pubmed_id>4873809</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4194.1 (1229.6) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Early preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3702.2 (713.5)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5500.0 +/- 160.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Growth hormone deficiency</patient_information>
      <comment>Induced by severe radiation
</comment>
      <references>
        <reference>
          <reference_text>Darzy KH, Murray RD, Gleeson HK, Pezzoli SS, Thorner MO, Shalet SM: The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J Clin Endocrinol Metab. 2006 Mar;91(3):987-94. Epub 2005 Dec 29.</reference_text>
          <pubmed_id>16384844</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>900-2200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</patient_information>
      <comment>n=2</comment>
      <references>
        <reference>
          <reference_text>Ozand PT, al Aqeel A, Gascon G, Brismar J, Thomas E, Gleispach H: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis. 1991;14(2):174-88.</reference_text>
          <pubmed_id>1886403</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>6000.0 (5000.0 - 6800.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Acute myelogenous leukemia (AML)</patient_information>
      <references>
        <reference>
          <reference_text>Tatidis L, Vitols S, Gruber A, Paul C, Axelson M: Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. Cancer Lett. 2001 Sep 20;170(2):169-75.</reference_text>
          <pubmed_id>11463495</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>200-2200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Ozand PT, al Aqeel A, Gascon G, Brismar J, Thomas E, Gleispach H: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis. 1991;14(2):174-88.</reference_text>
          <pubmed_id>1886403</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2100-2700</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <references>
        <reference>
          <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
          <pubmed_id>23430856</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2220.299</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Fructose-1,6-bisphosphatase deficiency</patient_information>
      <comment>Fasting 18 hours after stabilization on a high carbohydrate diet</comment>
      <references>
        <reference>
          <reference_text>Pagliara AS, Karl IE, Keating JP, Brown BI, Kipnis DM: Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J Clin Invest. 1972 Aug;51(8):2115-23. doi: 10.1172/JCI107018.</reference_text>
          <pubmed_id>4341015</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1665.224</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration</patient_information>
      <references>
        <reference>
          <reference_text>Lalani SR, Liu P, Rosenfeld JA, Watkin LB, Chiang T, Leduc MS, Zhu W, Ding Y, Pan S, Vetrini F, Miyake CY, Shinawi M, Gambin T, Eldomery MK, Akdemir ZH, Emrick L, Wilnai Y, Schelley S, Koenig MK, Memon N, Farach LS, Coe BP, Azamian M, Hernandez P, Zapata G, Jhangiani SN, Muzny DM, Lotze T, Clark G, Wilfong A, Northrup H, Adesina A, Bacino CA, Scaglia F, Bonnen PE, Crosson J, Duis J, Maegawa GH, Coman D, Inwood A, McGill J, Boerwinkle E, Graham B, Beaudet A, Eng CM, Hanchard NA, Xia F, Orange JS, Gibbs RA, Lupski JR, Yang Y: Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations. Am J Hum Genet. 2016 Feb 4;98(2):347-57. doi: 10.1016/j.ajhg.2015.12.008. Epub 2016 Jan 21.</reference_text>
          <pubmed_id>26805781</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>166.522</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Santarelli F, Cassanello M, Enea A, Poma F, D'Onofrio V, Guala G, Garrone G, Puccinelli P, Caruso U, Porta F, Spada M: A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr. 2013 May 24;39:33. doi: 10.1186/1824-7288-39-33.</reference_text>
          <pubmed_id>23705938</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1332.180-9436.272</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Donohue Syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Nijim Y, Awni Y, Adawi A, Bowirrat A: Classic Case Report of Donohue Syndrome (Leprechaunism; OMIM *246200): The Impact of Consanguineous Mating. Medicine (Baltimore). 2016 Feb;95(6):e2710. doi: 10.1097/MD.0000000000002710.</reference_text>
          <pubmed_id>26871809</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>444.0598-555.0748</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Fructose-1,6-bisphosphatase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Baker L, Winegrad AI: Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet. 1970 Jul 4;2(7662):13-6.</reference_text>
          <pubmed_id>4193749</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4329.583</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Leptin Deficiency or Dysfunction</patient_information>
      <references>
        <reference>
          <reference_text>Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999 Sep 16;341(12):879-84. doi: 10.1056/NEJM199909163411204.</reference_text>
          <pubmed_id>10486419</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>943.627</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration</patient_information>
      <references>
        <reference>
          <reference_text>Lalani SR, Liu P, Rosenfeld JA, Watkin LB, Chiang T, Leduc MS, Zhu W, Ding Y, Pan S, Vetrini F, Miyake CY, Shinawi M, Gambin T, Eldomery MK, Akdemir ZH, Emrick L, Wilnai Y, Schelley S, Koenig MK, Memon N, Farach LS, Coe BP, Azamian M, Hernandez P, Zapata G, Jhangiani SN, Muzny DM, Lotze T, Clark G, Wilfong A, Northrup H, Adesina A, Bacino CA, Scaglia F, Bonnen PE, Crosson J, Duis J, Maegawa GH, Coman D, Inwood A, McGill J, Boerwinkle E, Graham B, Beaudet A, Eng CM, Hanchard NA, Xia F, Orange JS, Gibbs RA, Lupski JR, Yang Y: Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations. Am J Hum Genet. 2016 Feb 4;98(2):347-57. doi: 10.1016/j.ajhg.2015.12.008. Epub 2016 Jan 21.</reference_text>
          <pubmed_id>26805781</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1909.457 +/- 233.131</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Glucagon deficiency</patient_information>
      <comment>n=7</comment>
      <references>
        <reference>
          <reference_text>Vidnes J, Oyasaeter S: Glucagon deficiency causing severe neonatal hypoglycemia in a patient with normal insulin secretion. Pediatr Res. 1977 Sep;11(9 Pt 1):943-9.</reference_text>
          <pubmed_id>904979</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4995.673-5106.688</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Primary Hypomagnesemia</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Jin-no Y, Kamiya Y, Okada M, Hirako M, Takada N, Kawaguchi M: Primary hypomagnesemia caused by isolated magnesium malabsorption: atypical case in adult. Intern Med. 1999 Mar;38(3):261-5.</reference_text>
          <pubmed_id>10337938</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2775.374-10213.376</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Proprotein Convertase 1/3 Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A, Gibson S, Taylor K, Carr C: Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1995 Nov 23;333(21):1386-90. doi: 10.1056/NEJM199511233332104.</reference_text>
          <pubmed_id>7477119</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2300</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
          <pubmed_id>12072887</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5114.0 +/- 483.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hyperlipidaemia </patient_information>
      <references>
        <reference>
          <reference_text>Sinha S, Misra A, Kumar V, Jagannathan NR, Bal CS, Pandey RM, Singhania R, Deepak: Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities. Clin Endocrinol (Oxf). 2004 Aug;61(2):182-9.</reference_text>
          <pubmed_id>15272912</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3241.19 (898.95) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetus having congenital heart defect</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3171.93 (754.22) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>800-1600</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=2</comment>
      <references>
        <reference>
          <reference_text>Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njolstad PR, Jellum E, Sovik O: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 2004 Jan;53(1):221-7.</reference_text>
          <pubmed_id>14693719</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>9300 +/- 5000</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes and Deafness, Maternally Inherited</patient_information>
      <comment>At end of 120 minute hyperglycemic clamp.</comment>
      <references>
        <reference>
          <reference_text>Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, Blanche H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P: Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes. 1996 Apr;45(4):478-87.</reference_text>
          <pubmed_id>8603770</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;2600</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Beckwith-Wiedemann Syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Martinez y Martinez R, Martinez-Carboney R, Ocampo-Campos R, Rivera H, Gomez Plascencia y Castillo J, Cuevas A, Martin Manrique MC: Wiedemann-Beckwith syndrome: clinical, cytogenetical and radiological observations in 39 new cases. Genet Couns. 1992;3(2):67-76.</reference_text>
          <pubmed_id>1642813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4312.9 (1783.0) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Late-onset preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>6300 +/- 2000</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes and Deafness, Maternally Inherited</patient_information>
      <references>
        <reference>
          <reference_text>Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, Blanche H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P: Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes. 1996 Apr;45(4):478-87.</reference_text>
          <pubmed_id>8603770</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3362.4 (765.9) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>6810 (5210-10250)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Familial partial lipodystrophy</patient_information>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5535.11(1872.49)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Heart failure with preserved ejection fraction</patient_information>
      <references>
        <reference>
          <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
          <pubmed_id>26010610</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>500-5200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Infantile Liver Failure Syndrome 2</patient_information>
      <references>
        <reference>
          <reference_text>Staufner C, Haack TB, Kopke MG, Straub BK, Kolker S, Thiel C, Freisinger P, Baric I, McKiernan PJ, Dikow N, Harting I, Beisse F, Burgard P, Kotzaeridou U, Lenz D, Kuhr J, Himbert U, Taylor RW, Distelmaier F, Vockley J, Ghaloul-Gonzalez L, Ozolek JA, Zschocke J, Kuster A, Dick A, Das AM, Wieland T, Terrile C, Strom TM, Meitinger T, Prokisch H, Hoffmann GF: Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis. 2016 Jan;39(1):3-16. doi: 10.1007/s10545-015-9896-7. Epub 2015 Nov 5.</reference_text>
          <pubmed_id>26541327</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Perez-Cerda C, Garcia-Villoria J, Ofman R, Sala PR, Merinero B, Ramos J, Garcia-Silva MT, Beseler B, Dalmau J, Wanders RJ, Ugarte M, Ribes A: 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease. Pediatr Res. 2005 Sep;58(3):488-91.</reference_text>
          <pubmed_id>16148061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by GC-MS</comment>
      <references>
        <reference>
          <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
          <pubmed_id>22007635</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by 1H NMR</comment>
      <references>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4812.499 +/- 288.639</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Evening. With Dexamethasone and Hydrocortisone treatment, high dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5112.239 +/- 427.408</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Evening. With Dexamethasone and Hydrocortisone treatment, standard dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4235.221 +/- 55.507</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Morning. With Dexamethasone and Hydrocortisone treatment, high dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4390.642 +/- 316.393</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Morning. With Dexamethasone and Hydrocortisone treatment, standard dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5600-7600</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Maturity onset diabetes of the young, type 2</patient_information>
      <comment>Fasting plasma glucose</comment>
      <references>
        <reference>
          <reference_text>Estalella I, Garcia-Gimeno MA, Marina A, Castano L, Sanz P: Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patients. J Hum Genet. 2008;53(5):460-6. doi: 10.1007/s10038-008-0271-5. Epub 2008 Mar 6.</reference_text>
          <pubmed_id>18322640</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1750.00 (500.00-3000.00)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hypoadrenocorticism</patient_information>
      <references>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1940 +/- 570</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hyperinsulinemic hypoglycemia, familial, 1, HHF1</patient_information>
      <comment>In diazoxide-resistant patients</comment>
      <references>
        <reference>
          <reference_text>Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, Czernichow P, Saudubray JM: Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr. 1998 Aug;157(8):628-33.</reference_text>
          <pubmed_id>9727845</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1900 +/- 700</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hyperinsulinemic hypoglycemia, familial, 1, HHF1</patient_information>
      <comment>In diazoxide-sensitive patients</comment>
      <references>
        <reference>
          <reference_text>Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, Czernichow P, Saudubray JM: Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr. 1998 Aug;157(8):628-33.</reference_text>
          <pubmed_id>9727845</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>600-1000</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hyperinsulinemic hypoglycemia, familial, 1, HHF1</patient_information>
      <references>
        <reference>
          <reference_text>Horev Z, Ipp M, Levey P, Daneman D: Familial hyperinsulinism: successful conservative management. J Pediatr. 1991 Nov;119(5):717-20.</reference_text>
          <pubmed_id>1941376</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>700-2600</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Mitochondrial trifunctional protein deficiency</patient_information>
      <references>
        <reference>
          <reference_text>den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA: Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr. 2003 Jun;142(6):684-9. doi: 10.1067/mpd.2003.231.</reference_text>
          <pubmed_id>12838198</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1500</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Carnitine palmitoyltransferase deficiency I</patient_information>
      <references>
        <reference>
          <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
          <pubmed_id>11286380</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>2800</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</patient_information>
      <comment>Four hours after ingestion of medium-chain triglycerides.</comment>
      <references>
        <reference>
          <reference_text>Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA: Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997 Oct 23;337(17):1203-7. doi: 10.1056/NEJM199710233371704.</reference_text>
          <pubmed_id>9337379</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;100</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Carnitine palmitoyltransferase deficiency I</patient_information>
      <references>
        <reference>
          <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
          <pubmed_id>11286380</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>390</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Carnitine transporter defect; primary systemic carnitine deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006.</reference_text>
          <pubmed_id>3185635</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>245.5 (96.0) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Down syndrome pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>217.3 (73.8) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>333.0449</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub  2008 Jan 8.</reference_text>
          <pubmed_id>18182448</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>555.0748</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub  2008 Jan 8.</reference_text>
          <pubmed_id>18182448</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4400.0 (3300.0-5500.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-methyl-crotonyl-glycinuria</patient_information>
      <references>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1750.0 (500.0-3000.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-Methyl-crotonyl-glycinuria</patient_information>
      <references>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>1837.260 +/- 271.980</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Glucose transporter type 1 deficiency syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP, De Vivo DC: Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol. 2005 Jan;57(1):111-8.</reference_text>
          <pubmed_id>15622525</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Long-chain Fatty Acids, Defect in Transport of</patient_information>
      <references>
        <reference>
          <reference_text>Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006.</reference_text>
          <pubmed_id>3185635</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>2053.777</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Leigh Syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Hommes FA, Polman HA, Reerink JD: Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child. 1968 Aug;43(230):423-6.</reference_text>
          <pubmed_id>4873809</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>3700.0 (3200.0-4200.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Carnitine transporter defect; primary systemic carnitine deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006.</reference_text>
          <pubmed_id>3185635</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>1900</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>GLUT1 deficiency syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Koy A, Assmann B, Klepper J, Mayatepek E: Glucose transporter type 1 deficiency syndrome with carbohydrate-responsive symptoms but without epilepsy. Dev Med Child Neurol. 2011 Dec;53(12):1154-6. doi: 10.1111/j.1469-8749.2011.04082.x. Epub 2011 Aug 12.</reference_text>
          <pubmed_id>21838819</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Immunoglobulin A nephropathy (IgAN) progressor</patient_information>
      <references>
        <reference>
          <reference_text>Barrios C, Spector TD, Menni C: Blood, urine and faecal metabolite profiles in the study of adult renal disease. Arch Biochem Biophys. 2016 Jan 1;589:81-92. doi: 10.1016/j.abb.2015.10.006. Epub  2015 Oct 21.</reference_text>
          <pubmed_id>26476344</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>Lyophilized feces samples (n=131) were used in the study. Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Premature neonates</patient_information>
      <comment>Wet feces samples (n=5) were used in the study.  Instrument: LC-MS. Technology specification: RP-HPLC-MS (Orbitrap),negative ionization mode.</comment>
      <references>
        <reference>
          <reference_text>Gregory KE, Bird SS, Gross VS, Marur VR, Lazarev AV, Walker WA, Kristal BS: Method development for fecal lipidomics profiling. Anal Chem. 2013 Jan 15;85(2):1114-23. doi: 10.1021/ac303011k. Epub 2012 Dec 26.</reference_text>
          <pubmed_id>23210743</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>asymptomatic diverticulosis</patient_information>
      <references>
        <reference>
          <reference_text>Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Capuani G, Tomassini A, Campagna G, Picchio M, Giorgetti G, Fabiocchi F, Brandimarte G: Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon. J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S9-S12. doi: 10.1097/MCG.0000000000000626.</reference_text>
          <pubmed_id>27622378</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>symptomatic uncomplicated diverticular disease</patient_information>
      <references>
        <reference>
          <reference_text>Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Capuani G, Tomassini A, Campagna G, Picchio M, Giorgetti G, Fabiocchi F, Brandimarte G: Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon. J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S9-S12. doi: 10.1097/MCG.0000000000000626.</reference_text>
          <pubmed_id>27622378</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal Cancer</patient_information>
      <references>
        <reference>
          <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
          <pubmed_id>27107423</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Ulcerative colitis</patient_information>
      <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.01, higher than control. </comment>
      <references>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal Cancer</patient_information>
      <references>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>&gt;5550.748</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Fanconi Bickel syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Late Diagnosis of Fanconi-Bickel Syndrome: Challenges With the Diagnosis and Literature Review </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>19700.0</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <references>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>79600.0 (68300.0-90900.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>With ketoacidosis
</comment>
      <references>
        <reference>
          <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
          <pubmed_id>6810706</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Bladder cancer</patient_information>
      <references>
        <reference>
          <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
          <pubmed_id>28157703</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by 1H NMR</comment>
      <references>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>17449.11 (137.28 - 129930.33) </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Type 1 diabetes Mellitus</patient_information>
      <references>
        <reference>
          <reference_text>Lorena Ivona ŞTEFAN, Alina NICOLESCU, Simona POPA, Maria MOŢA, Eugenia KOVACS and Calin DELEANU. 1H-NMR URINE METABOLIC PROFILING IN TYPE 1 DIABETES MELLITUS. Rev. Roum. Chim., 2010, 55(11-12), 1033-1037 </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>30.015 +/- 27.82</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
  </abnormal_concentrations>
  <diseases>
    <disease>
      <name>Growth hormone deficiency</name>
      <omim_id>139250</omim_id>
      <references>
        <reference>
          <reference_text>Rodriguez-Arnao J, James I, Jabbar A, Trainer PJ, Perrett D, Besser GM, Ross RJ: Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults. Clin Endocrinol (Oxf). 1998 Apr;48(4):455-62.</reference_text>
          <pubmed_id>9640412</pubmed_id>
        </reference>
        <reference>
          <reference_text>Burman P, Hetta J, Wide L, Mansson JE, Ekman R, Karlsson FA: Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clin Endocrinol (Oxf). 1996 Mar;44(3):319-24.</reference_text>
          <pubmed_id>8729530</pubmed_id>
        </reference>
        <reference>
          <reference_text>Darzy KH, Murray RD, Gleeson HK, Pezzoli SS, Thorner MO, Shalet SM: The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J Clin Endocrinol Metab. 2006 Mar;91(3):987-94. Epub 2005 Dec 29.</reference_text>
          <pubmed_id>16384844</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Acute myelogenous leukemia</name>
      <omim_id>602439</omim_id>
      <references>
        <reference>
          <reference_text>Tatidis L, Vitols S, Gruber A, Paul C, Axelson M: Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. Cancer Lett. 2001 Sep 20;170(2):169-75.</reference_text>
          <pubmed_id>11463495</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Hyperlipoproteinemia</name>
      <omim_id>238600</omim_id>
      <references>
        <reference>
          <reference_text>Sinha S, Misra A, Kumar V, Jagannathan NR, Bal CS, Pandey RM, Singhania R, Deepak: Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities. Clin Endocrinol (Oxf). 2004 Aug;61(2):182-9.</reference_text>
          <pubmed_id>15272912</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nelson RH: Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013 Mar;40(1):195-211. doi: 10.1016/j.pop.2012.11.003. Epub 2012 Dec  4.</reference_text>
          <pubmed_id>23402469</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cantin B, Boudriau S, Bertrand M, Brun LD, Gagne C, Rogers PA, Ven Murthy MR, Lupien PJ, Julien P: Hemolysis in primary lipoprotein lipase deficiency. Metabolism. 1995 May;44(5):652-8.</reference_text>
          <pubmed_id>7752915</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Methyl-crotonyl-glycinuria</name>
      <omim_id>210200</omim_id>
      <references>
        <reference>
          <reference_text>Rutledge SL, Berry GT, Stanley CA, van Hove JL, Millington D: Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency. J Inherit Metab Dis. 1995;18(3):299-305.</reference_text>
          <pubmed_id>7474896</pubmed_id>
        </reference>
        <reference>
          <reference_text>Thomsen JA, Lund AM, Olesen JH, Mohr M, Rasmussen J: Is L-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency? JIMD Rep. 2015;21:79-88. doi: 10.1007/8904_2014_393. Epub 2015 Mar 3.</reference_text>
          <pubmed_id>25732994</pubmed_id>
        </reference>
        <reference>
          <reference_text>Koeberl DD, Millington DS, Smith WE, Weavil SD, Muenzer J, McCandless SE, Kishnani PS, McDonald MT, Chaing S, Boney A, Moore E, Frazier DM: Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening. J Inherit Metab Dis. 2003;26(1):25-35.</reference_text>
          <pubmed_id>12872837</pubmed_id>
        </reference>
        <reference>
          <reference_text>de Kremer RD, Latini A, Suormala T, Baumgartner ER, Larovere L, Civallero G, Guelbert N, Paschini-Capra A, Depetris-Boldini C, Mayor CQ: Leukodystrophy and CSF purine abnormalities associated with isolated 3-methylcrotonyl-CoA carboxylase deficiency. Metab Brain Dis. 2002 Mar;17(1):13-8.</reference_text>
          <pubmed_id>11893004</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Addison's Disease</name>
      <omim_id>240200</omim_id>
      <references>
        <reference>
          <reference_text>Bornstein SR, Breidert M, Ehrhart-Bornstein M, Kloos B, Scherbaum WA: Plasma catecholamines in patients with Addison's disease. Clin Endocrinol (Oxf). 1995 Feb;42(2):215-8.</reference_text>
          <pubmed_id>7704967</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Early preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pregnancy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
          <pubmed_id>3252730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
          <pubmed_id>663967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
          <pubmed_id>12833386</pubmed_id>
        </reference>
        <reference>
          <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
          <pubmed_id>2994907</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
          <pubmed_id>17704099</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
          <pubmed_id>12698507</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
          <pubmed_id>17061063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
          <pubmed_id>16925883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
          <pubmed_id>22420377</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
          <pubmed_id>18059417</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
        <reference>
          <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Late-onset preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Glucagon deficiency</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Vidnes J, Oyasaeter S: Glucagon deficiency causing severe neonatal hypoglycemia in a patient with normal insulin secretion. Pediatr Res. 1977 Sep;11(9 Pt 1):943-9.</reference_text>
          <pubmed_id>904979</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Primary hypomagnesemia</name>
      <omim_id>248250</omim_id>
      <references>
        <reference>
          <reference_text>Jin-no Y, Kamiya Y, Okada M, Hirako M, Takada N, Kawaguchi M: Primary hypomagnesemia caused by isolated magnesium malabsorption: atypical case in adult. Intern Med. 1999 Mar;38(3):261-5.</reference_text>
          <pubmed_id>10337938</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vainsel M, Vandevelde G, Smulders J, Vosters M, Hubain P, Loeb H: Tetany due to hypomagnesaemia with secondary hypocalcaemia. Arch Dis Child. 1970 Apr;45(240):254-8.</reference_text>
          <pubmed_id>5419995</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shalev H, Phillip M, Galil A, Carmi R, Landau D: Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child. 1998 Feb;78(2):127-30.</reference_text>
          <pubmed_id>9579153</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kari JA, Farouq M, Alshaya HO: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol. 2003 Jun;18(6):506-10. Epub 2003 Apr 29.</reference_text>
          <pubmed_id>12720080</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxy-3-methylglutaryl-CoA lyase deficiency</name>
      <omim_id>246450</omim_id>
      <references>
        <reference>
          <reference_text>Jakobs C, Bojasch M, Duran M, Ketting D, Wadman SK, Leupold D: 3-methyl-3-butenoic acid: an artefact in the urinary metabolic pattern of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Clin Chim Acta. 1980 Sep 8;106(1):85-9.</reference_text>
          <pubmed_id>6157502</pubmed_id>
        </reference>
        <reference>
          <reference_text>Muroi J, Yorifuji T, Uematsu A, Shigematsu Y, Onigata K, Maruyama H, Nobutoki T, Kitamura A, Nakahata T: Molecular and clinical analysis of Japanese patients with 3-hydroxy-3-methylglutaryl CoA lyase (HL) deficiency. Hum Genet. 2000 Oct;107(4):320-6.</reference_text>
          <pubmed_id>11129331</pubmed_id>
        </reference>
        <reference>
          <reference_text>Grunert SC, Schlatter SM, Schmitt RN, Gemperle-Britschgi C, Mrazova L, Balci MC, Bischof F, Coker M, Das AM, Demirkol M, de Vries M, Gokcay G, Haberle J, Ucar SK, Lotz-Havla AS, Lucke T, Roland D, Rutsch F, Santer R, Schlune A, Staufner C, Schwab KO, Mitchell GA, Sass JO: 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients. Mol Genet Metab. 2017 Jul;121(3):206-215. doi: 10.1016/j.ymgme.2017.05.014. Epub  2017 May 22.</reference_text>
          <pubmed_id>28583327</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bischof F, Nagele T, Wanders RJ, Trefz FK, Melms A: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy. Ann Neurol. 2004 Nov;56(5):727-30.</reference_text>
          <pubmed_id>15505778</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dos Santos Mello M, Ribas GS, Wayhs CA, Hammerschmidt T, Guerreiro GB, Favenzani JL, Sitta A, de Moura Coelho D, Wajner M, Vargas CR: Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria. Mol Cell Biochem. 2015 Apr;402(1-2):149-55. doi: 10.1007/s11010-014-2322-x. Epub  2015 Jan 4.</reference_text>
          <pubmed_id>25557019</pubmed_id>
        </reference>
        <reference>
          <reference_text>Santarelli F, Cassanello M, Enea A, Poma F, D'Onofrio V, Guala G, Garrone G, Puccinelli P, Caruso U, Porta F, Spada M: A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr. 2013 May 24;39:33. doi: 10.1186/1824-7288-39-33.</reference_text>
          <pubmed_id>23705938</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ozand PT, al Aqeel A, Gascon G, Brismar J, Thomas E, Gleispach H: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis. 1991;14(2):174-88.</reference_text>
          <pubmed_id>1886403</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
          <pubmed_id>12072887</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leung AA, Chan AK, Ezekowitz JA, Leung AK: A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency. Case Rep Med. 2009;2009:183125. doi: 10.1155/2009/183125. Epub 2009 Nov 4.</reference_text>
          <pubmed_id>19893767</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</name>
      <omim_id>605911</omim_id>
      <references>
        <reference>
          <reference_text>Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA: Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997 Oct 23;337(17):1203-7. doi: 10.1056/NEJM199710233371704.</reference_text>
          <pubmed_id>9337379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021.</reference_text>
          <pubmed_id>9727719</pubmed_id>
        </reference>
        <reference>
          <reference_text>Conboy E, Vairo F, Schultz M, Agre K, Ridsdale R, Deyle D, Oglesbee D, Gavrilov D, Klee EW, Lanpher B: Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features. JIMD Rep. 2017 Oct 14. doi: 10.1007/8904_2017_59.</reference_text>
          <pubmed_id>29030856</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Short/branched chain acyl-CoA dehydrogenase deficiency</name>
      <omim_id>610006</omim_id>
      <references>
        <reference>
          <reference_text>Kanavin OJ, Woldseth B, Jellum E, Tvedt B, Andresen BS, Stromme P: 2-methylbutyryl-CoA dehydrogenase deficiency associated with autism and mental retardation: a case report. J Med Case Rep. 2007 Sep 20;1:98.</reference_text>
          <pubmed_id>17883863</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gibson KM, Burlingame TG, Hogema B, Jakobs C, Schutgens RB, Millington D, Roe CR, Roe DS, Sweetman L, Steiner RD, Linck L, Pohowalla P, Sacks M, Kiss D, Rinaldo P, Vockley J: 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of L-isoleucine metabolism. Pediatr Res. 2000 Jun;47(6):830-3.</reference_text>
          <pubmed_id>10832746</pubmed_id>
        </reference>
        <reference>
          <reference_text>Matern D, He M, Berry SA, Rinaldo P, Whitley CB, Madsen PP, van Calcar SC, Lussky RC, Andresen BS, Wolff JA, Vockley J: Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics. 2003 Jul;112(1 Pt 1):74-8.</reference_text>
          <pubmed_id>12837870</pubmed_id>
        </reference>
        <reference>
          <reference_text>Korman SH, Andresen BS, Zeharia A, Gutman A, Boneh A, Pitt JJ: 2-ethylhydracrylic aciduria in short/branched-chain acyl-CoA dehydrogenase deficiency: application to diagnosis and implications for the R-pathway of isoleucine oxidation. Clin Chem. 2005 Mar;51(3):610-7. Epub 2004 Dec 22.</reference_text>
          <pubmed_id>15615815</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sass JO, Ensenauer R, Roschinger W, Reich H, Steuerwald U, Schirrmacher O, Engel K, Haberle J, Andresen BS, Megarbane A, Lehnert W, Zschocke J: 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: functional and molecular studies on a defect in isoleucine catabolism. Mol Genet Metab. 2008 Jan;93(1):30-5. doi: 10.1016/j.ymgme.2007.09.002. Epub 2007 Oct 22.</reference_text>
          <pubmed_id>17945527</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>21-Hydroxylase deficiency</name>
      <omim_id>201910</omim_id>
      <references>
        <reference>
          <reference_text>Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE: Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006 Jun;91(6):2179-84. Epub 2006 Mar 21.</reference_text>
          <pubmed_id>16551734</pubmed_id>
        </reference>
        <reference>
          <reference_text>Turcu AF, Rege J, Chomic R, Liu J, Nishimoto HK, Else T, Moraitis AG, Palapattu GS, Rainey WE, Auchus RJ: Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency. J Clin Endocrinol Metab. 2015 Jun;100(6):2283-90. doi: 10.1210/jc.2015-1023. Epub 2015 Apr 7.</reference_text>
          <pubmed_id>25850025</pubmed_id>
        </reference>
        <reference>
          <reference_text>White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000 Jun;21(3):245-91. doi: 10.1210/edrv.21.3.0398.</reference_text>
          <pubmed_id>10857554</pubmed_id>
        </reference>
        <reference>
          <reference_text>Warinner SA, Zimmerman D, Thompson GB, Grant CS: Study of three patients with congenital adrenal hyperplasia treated by bilateral adrenalectomy. World J Surg. 2000 Nov;24(11):1347-52.</reference_text>
          <pubmed_id>11038205</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gmyrek GA, New MI, Sosa RE, Poppas DP: Bilateral laparoscopic adrenalectomy as a treatment for classic congenital adrenal hyperplasia attributable to 21-hydroxylase deficiency. Pediatrics. 2002 Feb;109(2):E28.</reference_text>
          <pubmed_id>11826238</pubmed_id>
        </reference>
        <reference>
          <reference_text>Falhammar H, Wedell A, Nordenstrom A: Biochemical and genetic diagnosis of 21-hydroxylase deficiency. Endocrine. 2015 Nov;50(2):306-14. doi: 10.1007/s12020-015-0731-6. Epub 2015 Sep 4.</reference_text>
          <pubmed_id>26336836</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxyacyl-CoA dehydrogenase deficiency</name>
      <omim_id>231530</omim_id>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njolstad PR, Jellum E, Sovik O: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 2004 Jan;53(1):221-7.</reference_text>
          <pubmed_id>14693719</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vilarinho L, Marques JS, Rocha H, Ramos A, Lopes L, Narayan SB, Bennett MJ: Diagnosis of a patient with a kinetic variant of medium and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by newborn screening. Mol Genet Metab. 2012 Jul;106(3):277-80. doi: 10.1016/j.ymgme.2012.04.005. Epub 2012 Apr 13.</reference_text>
          <pubmed_id>22579592</pubmed_id>
        </reference>
        <reference>
          <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
          <pubmed_id>23430856</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency</name>
      <omim_id>300438</omim_id>
      <references>
        <reference>
          <reference_text>Perez-Cerda C, Garcia-Villoria J, Ofman R, Sala PR, Merinero B, Ramos J, Garcia-Silva MT, Beseler B, Dalmau J, Wanders RJ, Ugarte M, Ribes A: 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease. Pediatr Res. 2005 Sep;58(3):488-91.</reference_text>
          <pubmed_id>16148061</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete</name>
      <omim_id>613743</omim_id>
      <references>
        <reference>
          <reference_text>Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub  2008 Jan 8.</reference_text>
          <pubmed_id>18182448</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</name>
      <omim_id>201810</omim_id>
      <references>
        <reference>
          <reference_text>Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9.</reference_text>
          <pubmed_id>7951484</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S: Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2002 Jun;87(6):2611-22. doi: 10.1210/jcem.87.6.8615.</reference_text>
          <pubmed_id>12050224</pubmed_id>
        </reference>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29.</reference_text>
          <pubmed_id>27476613</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Lipodystrophy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Lipodystrophy, Congenital Generalized</name>
      <omim_id>608594</omim_id>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Long-chain Fatty Acids, Defect in Transport of</name>
      <omim_id>603376</omim_id>
      <references>
        <reference>
          <reference_text>Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006.</reference_text>
          <pubmed_id>3185635</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Infantile Liver Failure Syndrome 2</name>
      <omim_id>616483</omim_id>
      <references>
        <reference>
          <reference_text>Staufner C, Haack TB, Kopke MG, Straub BK, Kolker S, Thiel C, Freisinger P, Baric I, McKiernan PJ, Dikow N, Harting I, Beisse F, Burgard P, Kotzaeridou U, Lenz D, Kuhr J, Himbert U, Taylor RW, Distelmaier F, Vockley J, Ghaloul-Gonzalez L, Ozolek JA, Zschocke J, Kuster A, Dick A, Das AM, Wieland T, Terrile C, Strom TM, Meitinger T, Prokisch H, Hoffmann GF: Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis. 2016 Jan;39(1):3-16. doi: 10.1007/s10545-015-9896-7. Epub 2015 Nov 5.</reference_text>
          <pubmed_id>26541327</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Partial lipodystrophy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Phosphoenolpyruvate Carboxykinase Deficiency 1, Cytosolic</name>
      <omim_id>261680</omim_id>
      <references>
        <reference>
          <reference_text>Vieira P, Cameron J, Rahikkala E, Keski-Filppula R, Zhang LH, Santra S, Matthews A, Myllynen P, Nuutinen M, Moilanen JS, Rodenburg RJ, Rolfs A, Uusimaa J, van Karnebeek CDM: Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction. Mol Genet Metab. 2017 Apr;120(4):337-341. doi: 10.1016/j.ymgme.2017.02.003. Epub  2017 Feb 6.</reference_text>
          <pubmed_id>28216384</pubmed_id>
        </reference>
        <reference>
          <reference_text>Santra S, Cameron JM, Shyr C, Zhang L, Drogemoller B, Ross CJ, Wasserman WW, Wevers RA, Rodenburg RJ, Gupte G, Preece MA, van Karnebeek CD: Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis. Mol Genet Metab. 2016 May;118(1):21-7. doi: 10.1016/j.ymgme.2016.03.001. Epub 2016 Mar 4.</reference_text>
          <pubmed_id>26971250</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Fructose-1,6-diphosphatase deficiency</name>
      <omim_id>229700</omim_id>
      <references>
        <reference>
          <reference_text>Pagliara AS, Karl IE, Keating JP, Brown BI, Kipnis DM: Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J Clin Invest. 1972 Aug;51(8):2115-23. doi: 10.1172/JCI107018.</reference_text>
          <pubmed_id>4341015</pubmed_id>
        </reference>
        <reference>
          <reference_text>Baker L, Winegrad AI: Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet. 1970 Jul 4;2(7662):13-6.</reference_text>
          <pubmed_id>4193749</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Hypoglycemia, familial neonatal</name>
      <omim_id>240800</omim_id>
      <references>
        <reference>
          <reference_text>COCHRANE WA, PAYNE WW, SIMPKISS MJ, WOOLF LI: Familial hypoglycemia precipitated by amino acids. J Clin Invest. 1956 Apr;35(4):411-22. doi: 10.1172/JCI103292.</reference_text>
          <pubmed_id>13306783</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Leigh's syndrome, subacute necrotizing encephalopathy, SNE</name>
      <omim_id>256000</omim_id>
      <references>
        <reference>
          <reference_text>Hommes FA, Polman HA, Reerink JD: Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child. 1968 Aug;43(230):423-6.</reference_text>
          <pubmed_id>4873809</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration</name>
      <omim_id>616878</omim_id>
      <references>
        <reference>
          <reference_text>Lalani SR, Liu P, Rosenfeld JA, Watkin LB, Chiang T, Leduc MS, Zhu W, Ding Y, Pan S, Vetrini F, Miyake CY, Shinawi M, Gambin T, Eldomery MK, Akdemir ZH, Emrick L, Wilnai Y, Schelley S, Koenig MK, Memon N, Farach LS, Coe BP, Azamian M, Hernandez P, Zapata G, Jhangiani SN, Muzny DM, Lotze T, Clark G, Wilfong A, Northrup H, Adesina A, Bacino CA, Scaglia F, Bonnen PE, Crosson J, Duis J, Maegawa GH, Coman D, Inwood A, McGill J, Boerwinkle E, Graham B, Beaudet A, Eng CM, Hanchard NA, Xia F, Orange JS, Gibbs RA, Lupski JR, Yang Y: Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations. Am J Hum Genet. 2016 Feb 4;98(2):347-57. doi: 10.1016/j.ajhg.2015.12.008. Epub 2016 Jan 21.</reference_text>
          <pubmed_id>26805781</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Donohue Syndrome</name>
      <omim_id>246200</omim_id>
      <references>
        <reference>
          <reference_text>Nijim Y, Awni Y, Adawi A, Bowirrat A: Classic Case Report of Donohue Syndrome (Leprechaunism; OMIM *246200): The Impact of Consanguineous Mating. Medicine (Baltimore). 2016 Feb;95(6):e2710. doi: 10.1097/MD.0000000000002710.</reference_text>
          <pubmed_id>26871809</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Leptin Deficiency or Dysfunction</name>
      <omim_id>614962</omim_id>
      <references>
        <reference>
          <reference_text>Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999 Sep 16;341(12):879-84. doi: 10.1056/NEJM199909163411204.</reference_text>
          <pubmed_id>10486419</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Proprotein Convertase 1/3 Deficiency</name>
      <omim_id>600955</omim_id>
      <references>
        <reference>
          <reference_text>O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A, Gibson S, Taylor K, Carr C: Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1995 Nov 23;333(21):1386-90. doi: 10.1056/NEJM199511233332104.</reference_text>
          <pubmed_id>7477119</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Maturity onset diabetes of the young, type 2</name>
      <omim_id>125851</omim_id>
      <references>
        <reference>
          <reference_text>Estalella I, Garcia-Gimeno MA, Marina A, Castano L, Sanz P: Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patients. J Hum Genet. 2008;53(5):460-6. doi: 10.1007/s10038-008-0271-5. Epub 2008 Mar 6.</reference_text>
          <pubmed_id>18322640</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Hyperinsulinemic hypoglycemia, familial, 1, HHF1</name>
      <omim_id>256450</omim_id>
      <references>
        <reference>
          <reference_text>Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, Czernichow P, Saudubray JM: Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr. 1998 Aug;157(8):628-33.</reference_text>
          <pubmed_id>9727845</pubmed_id>
        </reference>
        <reference>
          <reference_text>Horev Z, Ipp M, Levey P, Daneman D: Familial hyperinsulinism: successful conservative management. J Pediatr. 1991 Nov;119(5):717-20.</reference_text>
          <pubmed_id>1941376</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Mitochondrial trifunctional protein deficiency</name>
      <omim_id>609015</omim_id>
      <references>
        <reference>
          <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
          <pubmed_id>11978597</pubmed_id>
        </reference>
        <reference>
          <reference_text>den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA: Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr. 2003 Jun;142(6):684-9. doi: 10.1067/mpd.2003.231.</reference_text>
          <pubmed_id>12838198</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Carnitine palmitoyltransferase I deficiency</name>
      <omim_id>255120</omim_id>
      <references>
        <reference>
          <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
          <pubmed_id>11286380</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Carnitine transporter defect; primary systemic carnitine deficiency</name>
      <omim_id>212140</omim_id>
      <references>
        <reference>
          <reference_text>Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006.</reference_text>
          <pubmed_id>3185635</pubmed_id>
        </reference>
        <reference>
          <reference_text>Waber LJ, Valle D, Neill C, DiMauro S, Shug A: Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr. 1982 Nov;101(5):700-5.</reference_text>
          <pubmed_id>7131143</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Diabetes and Deafness, Maternally Inherited</name>
      <omim_id>520000</omim_id>
      <references>
        <reference>
          <reference_text>Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, Blanche H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P: Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes. 1996 Apr;45(4):478-87.</reference_text>
          <pubmed_id>8603770</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Beckwith-Wiedemann Syndrome</name>
      <omim_id>130650</omim_id>
      <references>
        <reference>
          <reference_text>Martinez y Martinez R, Martinez-Carboney R, Ocampo-Campos R, Rivera H, Gomez Plascencia y Castillo J, Cuevas A, Martin Manrique MC: Wiedemann-Beckwith syndrome: clinical, cytogenetical and radiological observations in 39 new cases. Genet Couns. 1992;3(2):67-76.</reference_text>
          <pubmed_id>1642813</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Familial partial lipodystrophy</name>
      <omim_id>608600</omim_id>
      <references>
        <reference>
          <reference_text>Akinci G, Topaloglu H, Demir T, Danyeli AE, Talim B, Keskin FE, Kadioglu P, Talip E, Altay C, Yaylali GF, Bilen H, Nur B, Demir L, Onay H, Akinci B: Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscul Disord. 2017 Oct;27(10):923-930. doi: 10.1016/j.nmd.2017.05.015. Epub 2017 Jun 1.</reference_text>
          <pubmed_id>28754454</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Fanconi Bickel syndrome</name>
      <omim_id>227810</omim_id>
      <references>
        <reference>
          <reference_text>Late Diagnosis of Fanconi-Bickel Syndrome: Challenges With the Diagnosis and Literature Review </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Wolcott-Rallison syndrome</name>
      <omim_id>226980</omim_id>
      <references>
        <reference>
          <reference_text>Neonatal diabetes in Wolcott-Rallison syndrome: a case report</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Alzheimer's disease</name>
      <omim_id>104300</omim_id>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
        <reference>
          <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
          <pubmed_id>11959400</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
          <pubmed_id>8595727</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
          <pubmed_id>15361288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
          <pubmed_id>15465626</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
          <pubmed_id>15061359</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
          <pubmed_id>10494443</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
          <pubmed_id>11255442</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
          <pubmed_id>12498967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
          <pubmed_id>16227558</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
          <pubmed_id>9720975</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
          <pubmed_id>12111441</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
          <pubmed_id>16244393</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
          <pubmed_id>8356878</pubmed_id>
        </reference>
        <reference>
          <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
          <pubmed_id>12391605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
          <pubmed_id>8478958</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
          <pubmed_id>21292280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
          <pubmed_id>20858978</pubmed_id>
        </reference>
        <reference>
          <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
          <pubmed_id>21474939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
          <pubmed_id>20523031</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
          <pubmed_id>11314776</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
          <pubmed_id>1716470</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Glucose transporter type 1 deficiency syndrome</name>
      <omim_id>606777</omim_id>
      <references>
        <reference>
          <reference_text>Klepper J, Diefenbach S, Kohlschutter A, Voit T: Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):321-7.</reference_text>
          <pubmed_id>14769490</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP, De Vivo DC: Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol. 2005 Jan;57(1):111-8.</reference_text>
          <pubmed_id>15622525</pubmed_id>
        </reference>
        <reference>
          <reference_text>Koy A, Assmann B, Klepper J, Mayatepek E: Glucose transporter type 1 deficiency syndrome with carbohydrate-responsive symptoms but without epilepsy. Dev Med Child Neurol. 2011 Dec;53(12):1154-6. doi: 10.1111/j.1469-8749.2011.04082.x. Epub 2011 Aug 12.</reference_text>
          <pubmed_id>21838819</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Colorectal cancer</name>
      <omim_id>114500</omim_id>
      <references>
        <reference>
          <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
          <pubmed_id>7482520</pubmed_id>
        </reference>
        <reference>
          <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
          <pubmed_id>19006102</pubmed_id>
        </reference>
        <reference>
          <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
          <pubmed_id>23940645</pubmed_id>
        </reference>
        <reference>
          <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
          <pubmed_id>24424155</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
          <pubmed_id>20156336</pubmed_id>
        </reference>
        <reference>
          <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
          <pubmed_id>19678709</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
          <pubmed_id>22148915</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
          <pubmed_id>21773981</pubmed_id>
        </reference>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
          <pubmed_id>27107423</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
          <pubmed_id>28587349</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Diverticular disease</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
          <pubmed_id>8723414</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Capuani G, Tomassini A, Campagna G, Picchio M, Giorgetti G, Fabiocchi F, Brandimarte G: Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon. J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S9-S12. doi: 10.1097/MCG.0000000000000626.</reference_text>
          <pubmed_id>27622378</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Ulcerative colitis</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
          <pubmed_id>21059682</pubmed_id>
        </reference>
        <reference>
          <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
          <pubmed_id>1740537</pubmed_id>
        </reference>
        <reference>
          <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
          <pubmed_id>17269711</pubmed_id>
        </reference>
        <reference>
          <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
          <pubmed_id>17314143</pubmed_id>
        </reference>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
          <pubmed_id>23516449</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
          <pubmed_id>23867873</pubmed_id>
        </reference>
        <reference>
          <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
          <pubmed_id>24811995</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
          <pubmed_id>26806034</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
          <pubmed_id>26848182</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Diabetes mellitus type 2</name>
      <omim_id>125853</omim_id>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.</reference_text>
          <pubmed_id>11887176</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.</reference_text>
          <pubmed_id>16731998</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
          <pubmed_id>15982426</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.</reference_text>
          <pubmed_id>10431355</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
          <pubmed_id>6810706</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.</reference_text>
          <pubmed_id>7758205</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.</reference_text>
          <pubmed_id>9357814</pubmed_id>
        </reference>
        <reference>
          <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
          <pubmed_id>14512036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
          <pubmed_id>12067838</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.</reference_text>
          <pubmed_id>17161231</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.</reference_text>
          <pubmed_id>11315839</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.</reference_text>
          <pubmed_id>17659063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.</reference_text>
          <pubmed_id>17705693</pubmed_id>
        </reference>
        <reference>
          <reference_text>McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.</reference_text>
          <pubmed_id>1456422</pubmed_id>
        </reference>
        <reference>
          <reference_text>Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.</reference_text>
          <pubmed_id>484160</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.</reference_text>
          <pubmed_id>8234346</pubmed_id>
        </reference>
        <reference>
          <reference_text>Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.</reference_text>
          <pubmed_id>9591306</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.</reference_text>
          <pubmed_id>16966827</pubmed_id>
        </reference>
        <reference>
          <reference_text>Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.</reference_text>
          <pubmed_id>7096503</pubmed_id>
        </reference>
        <reference>
          <reference_text>Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.</reference_text>
          <pubmed_id>2614280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.</reference_text>
          <pubmed_id>18760976</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.</reference_text>
          <pubmed_id>11815509</pubmed_id>
        </reference>
        <reference>
          <reference_text>Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.</reference_text>
          <pubmed_id>10694785</pubmed_id>
        </reference>
        <reference>
          <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
          <pubmed_id>17919531</pubmed_id>
        </reference>
        <reference>
          <reference_text>Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.</reference_text>
          <pubmed_id>17190852</pubmed_id>
        </reference>
        <reference>
          <reference_text>Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.</reference_text>
          <pubmed_id>22031514</pubmed_id>
        </reference>
        <reference>
          <reference_text>Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013  May 2.</reference_text>
          <pubmed_id>23637065</pubmed_id>
        </reference>
        <reference>
          <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Rosa Va ́zquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study.  Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Diabetes mellitus type 1</name>
      <omim_id>222100</omim_id>
      <references>
        <reference>
          <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
          <pubmed_id>12067838</pubmed_id>
        </reference>
        <reference>
          <reference_text>van der Kloet FM, Tempels FW, Ismail N, van der Heijden R, Kasper PT, Rojas-Cherto M, van Doorn R, Spijksma G, Koek M, van der Greef J, Makinen VP, Forsblom C, Holthofer H, Groop PH, Reijmers TH, Hankemeier T: Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics. 2012 Feb;8(1):109-119. Epub 2011 Feb 24.</reference_text>
          <pubmed_id>22279428</pubmed_id>
        </reference>
        <reference>
          <reference_text>Granado-Lorencio F, Olmedilla-Alonso B, Blanco-Navarro I, Botella-Romero F, Simal-Anton A: Assessment of carotenoid status and the relation to glycaemic control in type I diabetics: a follow-up study. Eur J Clin Nutr. 2006 Aug;60(8):1000-8. Epub 2006 Feb 1.</reference_text>
          <pubmed_id>16452910</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lorena Ivona ŞTEFAN, Alina NICOLESCU, Simona POPA, Maria MOŢA, Eugenia KOVACS and Calin DELEANU. 1H-NMR URINE METABOLIC PROFILING IN TYPE 1 DIABETES MELLITUS. Rev. Roum. Chim., 2010, 55(11-12), 1033-1037 </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Eosinophilic esophagitis</name>
      <omim_id>610247</omim_id>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Schizophrenia</name>
      <omim_id>181500</omim_id>
      <references>
        <reference>
          <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
          <pubmed_id>115032</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
          <pubmed_id>7126379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
          <pubmed_id>2480613</pubmed_id>
        </reference>
        <reference>
          <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
          <pubmed_id>17276036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
          <pubmed_id>11877547</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
          <pubmed_id>12796220</pubmed_id>
        </reference>
        <reference>
          <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
          <pubmed_id>7595563</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
          <pubmed_id>20814316</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
        <reference>
          <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
          <pubmed_id>24713860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
          <pubmed_id>23823132</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
          <pubmed_id>2415198</pubmed_id>
        </reference>
        <reference>
          <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
          <pubmed_id>1694425</pubmed_id>
        </reference>
        <reference>
          <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
          <pubmed_id>7711000</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
          <pubmed_id>19390223</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
        <reference>
          <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
          <pubmed_id>22007635</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
          <pubmed_id>21483431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
          <pubmed_id>3741918</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
          <pubmed_id>11979513</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
          <pubmed_id>20206656</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
          <pubmed_id>436860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
          <pubmed_id>19401681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
          <pubmed_id>6184954</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
          <pubmed_id>26952797</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
        <reference>
          <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
          <pubmed_id>24789758</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
          <pubmed_id>22944140</pubmed_id>
        </reference>
        <reference>
          <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
          <pubmed_id>22892715</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
          <pubmed_id>17440431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
          <pubmed_id>25729574</pubmed_id>
        </reference>
        <reference>
          <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
          <pubmed_id>22257447</pubmed_id>
        </reference>
      </references>
    </disease>
  </diseases>
  <foodb_id>FDB012530</foodb_id>
  <chemspider_id>5589</chemspider_id>
  <pubchem_compound_id>5793</pubchem_compound_id>
  <pdb_id/>
  <chebi_id>4167</chebi_id>
  <drugbank_id/>
  <phenol_explorer_compound_id/>
  <knapsack_id>C00001122</knapsack_id>
  <kegg_id>C00031</kegg_id>
  <bigg_id>33582</bigg_id>
  <wikipedia_id>Glucose</wikipedia_id>
  <metlin_id>133</metlin_id>
  <biocyc_id>D-Glucose</biocyc_id>
  <synthesis_reference>Li, Dalin; Ruan, Yi; Song, Wen; Wang, Yongjun.  Improved process for producing glucose.  Faming Zhuanli Shenqing Gongkai Shuomingshu  (2003),     4 pp</synthesis_reference>
  <general_references>
    <reference>
      <reference_text>Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendy H, Mahmoody M: Fungal infections in solid organ recipients. Exp Clin Transplant. 2005 Dec;3(2):385-9.</reference_text>
      <pubmed_id>16417449</pubmed_id>
    </reference>
    <reference>
      <reference_text>Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC: Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol. 1999 Apr;33(4):652-8.</reference_text>
      <pubmed_id>10218738</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhao J, Wu LF: [Study of the causes of fetal growth restriction with unclear etiologies]. Zhonghua Fu Chan Ke Za Zhi. 2004 May;39(5):329-33.</reference_text>
      <pubmed_id>15196417</pubmed_id>
    </reference>
    <reference>
      <reference_text>Flynn DM, Fairney A, Jackson D, Clayton BE: Hormonal changes in thalassaemia major. Arch Dis Child. 1976 Nov;51(11):828-36.</reference_text>
      <pubmed_id>1008588</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sokup A, Swiatkowski M, Tyloch M, Skublicki S, Szymanski W, Goralczyk K: [Insulin secretion at the diagnosis of gestational diabetes is lower in multiparas than in primiparas]. Ginekol Pol. 2006 Jan;77(1):4-9.</reference_text>
      <pubmed_id>16736954</pubmed_id>
    </reference>
    <reference>
      <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
      <pubmed_id>15627241</pubmed_id>
    </reference>
    <reference>
      <reference_text>Roberts E: The importance of being dehydroepiandrosterone sulfate (in the blood of primates): a longer and healthier life? Biochem Pharmacol. 1999 Feb 15;57(4):329-46.</reference_text>
      <pubmed_id>9933021</pubmed_id>
    </reference>
    <reference>
      <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
      <pubmed_id>9693263</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kodama H, Okada S, Inui K, Yutaka T, Yabuuchi H: Studies on alpha-ketoglutaric aciduria in type I glycogenosis. Tohoku J Exp Med. 1980 Aug;131(4):347-53.</reference_text>
      <pubmed_id>6936873</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gollan JL, Huang SN, Billing B, Sherlock S: Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies. Gastroenterology. 1975 Jun;68(6):1543-55.</reference_text>
      <pubmed_id>805737</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hourd P, Edge JA, Dunger DB, Dalton N, Edwards R: Urinary growth hormone excretion during puberty in type 1 (insulin-dependent) diabetes mellitus. Diabet Med. 1991 Apr;8(3):237-42.</reference_text>
      <pubmed_id>1828739</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zebrower ME, Kieras FJ, Brown WT: Analysis by high-performance liquid chromatography of hyaluronic acid and chondroitin sulfates. Anal Biochem. 1986 Aug 15;157(1):93-9.</reference_text>
      <pubmed_id>3094400</pubmed_id>
    </reference>
    <reference>
      <reference_text>Commodari F, Arnold DL, Sanctuary BC, Shoubridge EA: 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient. NMR Biomed. 1991 Aug;4(4):192-200.</reference_text>
      <pubmed_id>1931558</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sakai T, Suzuki J, Marumo F, Kikawada R: A case of Fanconi syndrome with type 1 renal tubular acidosis. Jpn Circ J. 1981 Oct;45(10):1164-9.</reference_text>
      <pubmed_id>7299995</pubmed_id>
    </reference>
    <reference>
      <reference_text>Rohdewald VP, Rehder J, Mollmann H, Barth J, Derendorf H: [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate]. Arzneimittelforschung. 1987 Feb;37(2):194-8.</reference_text>
      <pubmed_id>3580023</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
      <pubmed_id>6810706</pubmed_id>
    </reference>
    <reference>
      <reference_text>Brodehl J, Oemar BS, Hoyer PF: Renal glucosuria. Pediatr Nephrol. 1987 Jul;1(3):502-8.</reference_text>
      <pubmed_id>3153324</pubmed_id>
    </reference>
    <reference>
      <reference_text>KASER H, COTTIER P, ANTENER I: Glucoglycinuria, a new familial syndrome. J Pediatr. 1962 Sep;61:386-94.</reference_text>
      <pubmed_id>14454131</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
      <pubmed_id>6321058</pubmed_id>
    </reference>
    <reference>
      <reference_text>Harada H, Shimizu H, Maeiwa M: 1H-NMR of human saliva. An application of NMR spectroscopy in forensic science. Forensic Sci Int. 1987 Jul;34(3):189-95.</reference_text>
      <pubmed_id>3666622</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.</reference_text>
      <pubmed_id>19212411</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
      <pubmed_id>32033212</pubmed_id>
    </reference>
  </general_references>
  <protein_associations>
    <protein>
      <protein_accession>HMDBP00210</protein_accession>
      <name>Glucokinase</name>
      <uniprot_id>P35557</uniprot_id>
      <gene_name>GCK</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00212</protein_accession>
      <name>Hexokinase-3</name>
      <uniprot_id>P52790</uniprot_id>
      <gene_name>HK3</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00213</protein_accession>
      <name>Hexokinase-2</name>
      <uniprot_id>P52789</uniprot_id>
      <gene_name>HK2</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00215</protein_accession>
      <name>Hexokinase-1</name>
      <uniprot_id>P19367</uniprot_id>
      <gene_name>HK1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00290</protein_accession>
      <name>Sucrase-isomaltase, intestinal</name>
      <uniprot_id>P14410</uniprot_id>
      <gene_name>SI</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00365</protein_accession>
      <name>Lactase-phlorizin hydrolase</name>
      <uniprot_id>P09848</uniprot_id>
      <gene_name>LCT</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00366</protein_accession>
      <name>Neutral alpha-glucosidase AB</name>
      <uniprot_id>Q14697</uniprot_id>
      <gene_name>GANAB</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00367</protein_accession>
      <name>Glycogen debranching enzyme</name>
      <uniprot_id>P35573</uniprot_id>
      <gene_name>AGL</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00369</protein_accession>
      <name>ADP-dependent glucokinase</name>
      <uniprot_id>Q9BRR6</uniprot_id>
      <gene_name>ADPGK</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00371</protein_accession>
      <name>Beta-1,4-galactosyltransferase 2</name>
      <uniprot_id>O60909</uniprot_id>
      <gene_name>B4GALT2</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00372</protein_accession>
      <name>Alpha-lactalbumin</name>
      <uniprot_id>P00709</uniprot_id>
      <gene_name>LALBA</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00374</protein_accession>
      <name>Trehalase</name>
      <uniprot_id>O43280</uniprot_id>
      <gene_name>TREH</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00376</protein_accession>
      <name>Glucose-6-phosphatase</name>
      <uniprot_id>P35575</uniprot_id>
      <gene_name>G6PC</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00377</protein_accession>
      <name>Beta-1,4-galactosyltransferase 1</name>
      <uniprot_id>P15291</uniprot_id>
      <gene_name>B4GALT1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00723</protein_accession>
      <name>Alpha-galactosidase A</name>
      <uniprot_id>P06280</uniprot_id>
      <gene_name>GLA</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00806</protein_accession>
      <name>Glucose-6-phosphate isomerase</name>
      <uniprot_id>P06744</uniprot_id>
      <gene_name>GPI</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01107</protein_accession>
      <name>Phosphoglucomutase-1</name>
      <uniprot_id>P36871</uniprot_id>
      <gene_name>PGM1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01795</protein_accession>
      <name>Glucosylceramidase</name>
      <uniprot_id>P04062</uniprot_id>
      <gene_name>GBA</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01817</protein_accession>
      <name>Lysosomal alpha-glucosidase</name>
      <uniprot_id>P10253</uniprot_id>
      <gene_name>GAA</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP02114</protein_accession>
      <name>Solute carrier family 2, facilitated glucose transporter member 1</name>
      <uniprot_id>P11166</uniprot_id>
      <gene_name>SLC2A1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP02909</protein_accession>
      <name>Glucokinase regulatory protein</name>
      <uniprot_id>Q14397</uniprot_id>
      <gene_name>GCKR</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03061</protein_accession>
      <name>Cytosolic beta-glucosidase</name>
      <uniprot_id>Q9H227</uniprot_id>
      <gene_name>GBA3</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03069</protein_accession>
      <name>Maltase-glucoamylase, intestinal</name>
      <uniprot_id>O43451</uniprot_id>
      <gene_name>MGAM</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP05099</protein_accession>
      <name>Glucose-6-phosphatase 3</name>
      <uniprot_id>Q9BUM1</uniprot_id>
      <gene_name>G6PC3</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP05100</protein_accession>
      <name>Glucose-6-phosphatase 2</name>
      <uniprot_id>Q9NQR9</uniprot_id>
      <gene_name>G6PC2</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP05979</protein_accession>
      <name>Neutral alpha-glucosidase C</name>
      <uniprot_id>Q8TET4</uniprot_id>
      <gene_name>GANC</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP09169</protein_accession>
      <name>Non-lysosomal glucosylceramidase</name>
      <uniprot_id>Q9HCG7</uniprot_id>
      <gene_name>GBA2</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP11783</protein_accession>
      <name>Putative hexokinase HKDC1</name>
      <uniprot_id>Q2TB90</uniprot_id>
      <gene_name>HKDC1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP11831</protein_accession>
      <name>Mannosyl-oligosaccharide glucosidase</name>
      <uniprot_id>Q13724</uniprot_id>
      <gene_name>MOGS</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
  </protein_associations>
</metabolite>
</hmdb>